KALV / KalVista Pharmaceuticals, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

KalVista Pharmaceuticals, Inc.
US ˙ NasdaqGM ˙ US4834971032

Akcje zaległe 53,240,888 shares
Akcje insidera30 294 646 shares
Własność insidera56,90 %
Insiderzy ogółem62
Wynik sentymentu insiderów

Ocena sentymentu insiderów pokazuje firmy, które są kupowane przez insiderów korporacyjnych.

Jest to wynik zaawansowanego, wieloczynnikowego modelu ilościowego, który identyfikuje spółki o najwyższym poziomie akumulacji informacji poufnych. Model rankingowy wykorzystuje kombinację liczby netto insiderów kupujących w ciągu ostatnich 90 dni, całkowitej liczby akcji kupionych jako procent akcji w obrocie oraz całkowitej liczby akcji posiadanych przez insiderów. Liczba ta waha się od 0 do 100, przy czym wyższe liczby wskazują na wyższy poziom akumulacji w porównaniu z innymi spółkami, a 50 to średnia.

Częstotliwość aktualizacji: codziennie

Zobacz najlepsze wybory dokonane przez insiderów, które zawierają listę firm o największej akumulacji informacji poufnych.

Zobacz akcje o najwyższym rankingu
Ocena sentymentu kadry kierowniczej

Ocena sentymentu kadry kierowniczej pokazuje, że firmy są kupowane przez urzędników korporacyjnych.

Z definicji dyrektorzy korporacyjni to insiderzy korporacyjni, ale w przeciwieństwie do niektórych innych insiderów (10% akcjonariuszy i członków zarządu), dyrektorzy pracują dla firmy na co dzień i podczas handlu korzystają z własnych pieniędzy. (10% Akcjonariusze i członkowie zarządu często zarządzają funduszami zarządzających pieniędzmi innych osób). W związku z tym transakcje wykorzystujące informacje poufne dokonywane przez osoby z kadry kierowniczej mają znacznie większe znaczenie i powinny być odpowiednio traktowane.

Podobnie jak ocena sentymentu insiderów, ocena sentymentu kadry kierowniczej jest wynikiem zaawansowanego, wieloczynnikowego modelu ilościowego, który identyfikuje firmy o najwyższym poziomie akumulacji urzędników.

Częstotliwość aktualizacji: codziennie

Zobacz najlepsze wybory dokonane przez insiderów, zobaczysz listę firm o najwyższym sentymencie insiderów.

Zobacz akcje o najwyższym rankingu
Kluczowe wskaźniki insider

Ta karta pokazuje pozycję firmy według różnych wskaźników insider. Ranking według miary percentyla pokazuje, jak ta firma wypada na tle innych firm na rynkach amerykańskich. Wyższe rankingi wskazują na lepszą sytuację.

Na przykład ogólnie przyjmuje się, że kupowanie przez insiderów jest pozytywnym wskaźnikiem, zatem spółki z większą liczbą takich transakcji plasowałyby się wyżej niż spółki z mniejszą liczbą takich transakcji (lub nawet sprzedaży przez insiderów.

Liczba netto zakupów dokonanych przez insiderów (ranking)

-6 ( )
10737 out of 10948

Liczba netto zakupów dokonanych przez insiderów to łączna liczba insiderów kupujących pomniejszona o całkowitą liczbę insiderów sprzedających w ciągu ostatnich 90 dni. Tutaj pokazana jest miara percentyla (zakres od 0 do 100%).

Procent akcji kupowanych przez insiderów (ranking)

-0.793% ( )
10595 out of 10786

Procent akcji zakupionych przez insiderów to całkowita liczba akcji zakupionych przez insiderów pomniejszona o całkowitą liczbę akcji sprzedanych przez insiderów w ciągu ostatnich 90 dni, podzielona przez całkowitą liczbę akcji zakupionych przez insiderów i pomnożona przez 100.

Wykres handlu insider

Poniższy wykres przedstawia KalVista Pharmaceuticals, Inc. transakcji zrealizowanych przez insiderów. Insiderzy to członkowie kadry kierowniczej, dyrektorzy lub znaczący inwestorzy w spółce. Ogólnie rzecz biorąc, dokonywanie transakcji w ich firmach przez osoby posiadające dostęp do informacji poufnych w oparciu o istotne, niepubliczne informacje jest generalnie nielegalne. Nie oznacza to, że dokonywanie jakichkolwiek transakcji we własnych firmach jest nielegalne. Muszą jednak zgłaszać wszystkie transakcje do SEC za pośrednictwem formularza 4.

Lista insiderów i wskaźniki rentowności

Ta tabela przedstawia listę znanych insiderów i jest generowana automatycznie na podstawie zgłoszeń ujawnianych SEC. Oprócz nazwisk, najnowszego tytułu oraz oznaczenia dyrektora, członka kierownictwa lub 10% właściciela, podajemy najnowsze ujawnione pakiety akcji. Dodatkowo, jeśli to możliwe, udostępniamy historyczne wyniki handlowe danego insidera. Historyczne wyniki handlowe to średnia ważona wyników rzeczywistych transakcji zakupu na otwartym rynku dokonanych przez insiderów. Więcej informacji na temat sposobu obliczania tej wartości obejrzyj webinar na YouTube.

See our leaderboard of most profitable insider traders.

Insider Średni zysk (%) Posiadane
Akcje		 Podział
korygujący
Acmp Iv Llc 10% Owner - [10%] 4 343 550 4 343 550
Acp Iv, L.p. 10% Owner - [10%] 4 343 550 4 343 550
Richard Aldrich Director - [D] 934 484 934 484
Audhya Paul K. CHIEF MEDICAL OFFICER - [O] 150 260 150 260
Steven L Basta Director - [D] 0 0
Albert Cha Director - [D] 0 0
Bruce A Cleveland 10% Owner - [10%] 4 619 196 4 619 196
David M Clapper 29 000
Thomas Andrew Crockett CEO, Director - [D] [O] 211 203 211 203
Martin Edwards Director - [D] 0 0
Feener Edward P. CHIEF SCIENTIFIC OFFICER - [O] 72 858 72 858
Philip T Gianos 10% Owner - [10%] 4 619 196 4 619 196
Gravett David M. 100 000
W Stephen Holmes 10% Owner - [10%] 4 619 196 4 619 196
InterWest Management Partners IX, LLC 10% Owner - [10%] 4 619 196 4 619 196
InterWest Partners IX, LP 10% Owner - [10%] 4 619 196 4 619 196
Daniel Janney 10% Owner - [10%] 4 343 550 4 343 550
Keith Katkin 29 000
Nina S Kjellson 10% Owner - [10%] 4 619 196 4 619 196
Gilbert H Kliman 10% Owner - [10%] 4 619 196 4 619 196
Insider Średni zysk (%) Posiadane
Akcje		 Podział
korygujący
Bong Y Koh 10% Owner - [10%] 1 544 112 5 089 354
Peter Kolchinsky 10% Owner - [10%] 1 441 070 1 441 070
Hayley Lewis 33 181
Andreas Maetzel Senior Vice President, Medical - [O] 0 0
Marcee Maroney VP, Clinical Affairs - [O] 0 0
John McKune 10 000
Khaled Nasr 10% Owner - [10%] 4 619 196 4 619 196
Guy P Nohra Director - [D] 4 343 550 4 343 550
A/S Novo 10% Owner - [10%] 0 0
Arnold L Oronsky 10% Owner - [10%] 388 766 388 766
Benjamin L Palleiko CHIEF EXECUTIVE OFFICER, Director - [D] [O] 479 989 479 989
Douglas A Pepper 10% Owner - [10%] 4 619 196 4 619 196
Brian JG Pereira Director - [D] 0 0
Brian Piekos Chief Financial Officer - [O] 21 661 21 661
Ra Capital Management, Llc Director, 10% Owner - [D] [10%] 1 441 070 1 441 070
RA Capital Healthcare Fund LP 10% Owner - [10%] 591 070 591 070
Premchandran Ramiya 60 586
David Renzi President & CEO, Director - [D] [O] 0 0
Joshua Resnick Director - [D] 71 211 71 211
Daniel B Soland Director - [D] 10 000 10 000
Sv Life Sciences Fund Iv Strategic Partners, L. P. 10% Owner - [10%] 47 471 47 471
Insider Średni zysk (%) Posiadane
Akcje		 Podział
korygujący
Sv Life Sciences Fund Iv, L.p. 10% Owner - [10%] 47 471 47 471
SV Life Sciences Fund IV (GP), L.P. 10% Owner - [10%] 47 471 47 471
Svlsf Iv, Llc 10% Owner - [10%] 47 471 47 471
David Joseph Saul 56 000
Nimish P Shah 10% Owner - [10%] 1 544 112 5 089 354
Shah Rajeev M. Director, 10% Owner - [D] [10%] 1 441 070 1 441 070
Michael David Smith Senior VP, Development - [O] 0 0
Nicole Sweeny Chief Commercial Officer - [O] 59 291 59 291
Patrick Treanor 17 000
Edward W Unkart 10 000
VHCP Co-Investment Holdings II, LLC 10% Owner - [10%] 1 544 112 1 544 112
VHCP Co-Investment Holdings III, LLC 10% Owner - [10%] 1 544 112 5 089 354
VHCP Management II, LLC 10% Owner - [10%] 1 544 112 1 544 112
VHCP Management III, LLC 10% Owner - [10%] 1 544 112 5 089 354
Vivo Ventures Vi Affiilates Fund, L.p. 10% Owner - [10%] 4 204 562 4 204 562
Venrock Healthcare Capital Partners II, L.P. 10% Owner - [10%] 1 544 112 1 544 112
Venrock Healthcare Capital Partners III, L.P. 10% Owner - [10%] 5 089 354 5 089 354
Vivo Ventures Fund VI, L.P. 10% Owner - [10%] 4 204 562 4 204 562
Vivo Ventures VI, LLC 10% Owner - [10%] 4 204 562 4 204 562
Christopher Yea CHIEF DEVELOPMENT OFFICER - [O] 229 918 229 918
Reza Zadno 15 750

Report errors via our new Insider Auditing Tool

Śledź historię zakupów insiderów — analiza zysków krótkoterminowych

W tej sekcji analizujemy rentowność każdego nieplanowanego zakupu od poufnych informacji na otwartym rynku dokonanego w KALV / KalVista Pharmaceuticals, Inc.. Analiza ta pomaga zrozumieć, czy insider konsekwentnie generuje nietypowe zyski i czy warto ją śledzić. Analiza ta obejmuje okres jednego roku po każdej transakcji wyniki są teoretyczne .

Poniższa tabela przedstawia najnowsze zakupy na otwartym rynku, które nie były częścią planu handlu automatycznego.

Data transakcji Insider Zgłoszone
Akcje		 Zgłoszona
Cena		 Skorygowane
Akcje		 Skorygowana
Cena		 Podstawa kalkulacji kosztów Dni do
Maks		 Cena
Maks		 Maks
Zysk ($)		 Maks zwrot (%)
2025-04-09 Venrock Healthcare Capital Partners III, L.P. 25 000 9,4200 25 000 9,4200 235 500 362 20.1900 269 250 114,33
2025-02-13 Venrock Healthcare Capital Partners III, L.P. 61 700 9,3300 61 700 9,3300 575 661
2025-02-12 Venrock Healthcare Capital Partners III, L.P. 100 000 9,2300 100 000 9,2300 923 000
2025-02-11 Venrock Healthcare Capital Partners III, L.P. 26 703 9,1800 26 703 9,1800 245 134
2025-02-10 Venrock Healthcare Capital Partners III, L.P. 4 137 9,1400 4 137 9,1400 37 812
2025-02-07 Venrock Healthcare Capital Partners III, L.P. 73 649 9,2900 73 649 9,2900 684 199
2025-02-03 Venrock Healthcare Capital Partners III, L.P. 14 562 9,2200 14 562 9,2200 134 262
2025-01-31 Venrock Healthcare Capital Partners III, L.P. 11 754 8,8900 11 754 8,8900 104 493
2025-01-30 Venrock Healthcare Capital Partners III, L.P. 43 707 8,7600 43 707 8,7600 382 873

Cena skorygowana to cena skorygowana o podział. Akcje skorygowane to akcje skorygowane o podział.

KALV / KalVista Pharmaceuticals, Inc. Insider Trades
Śledź historię sprzedaży insider — analiza strat krótkoterminowych

W tej sekcji analizujemy możliwość uniknięcia krótkoterminowych strat w wyniku każdej nieplanowanej sprzedaży insidera na otwartym rynku dokonanej w KALV / KalVista Pharmaceuticals, Inc.. Konsekwentny wzorzec unikania strat może sugerować, że przyszłe transakcje sprzedaży mogą przewidywać spadki cen. Analiza ta obejmuje okres jednego roku po każdej transakcji wyniki są teoretyczne .

Poniższa tabela przedstawia najnowsze sprzedaże na otwartym rynku, które nie były częścią planu handlu automatycznego.

Data transakcji Insider Zgłoszone
Akcje		 Zgłoszona
Cena		 Skorygowane
Akcje		 Skorygowana
Cena		 Podstawa kalkulacji kosztów Dni do
Min		 Cena
Min		 Maksymalna strata
Uniknięto ($)		 Maksymalna strata
Uniknięto (%)
2026-05-27 Yea Christopher 33 800 26,7818 33 800 26,7818 905 225 1 26.7700 -398 -0,04
2026-05-26 Yea Christopher 1 966 26,7778 1 966 26,7778 52 645
2026-05-26 Sweeny Nicole 1 489 26,7778 1 489 26,7778 39 872
2026-05-26 Audhya Paul K. 2 239 26,7778 2 239 26,7778 59 955
2026-05-22 Piekos Brian 1 489 26,7844 1 489 26,7844 39 882
2026-05-22 Audhya Paul K. 2 685 26,7844 2 685 26,7844 71 916
2026-05-22 Sweeny Nicole 1 861 26,7844 1 861 26,7844 49 846
2026-05-22 Yea Christopher 2 358 26,7844 2 358 26,7844 63 158
2026-05-22 Palleiko Benjamin L 10 926 26,7844 10 926 26,7844 292 646

Cena skorygowana to cena skorygowana o podział. Akcje skorygowane to akcje skorygowane o podział.

KALV / KalVista Pharmaceuticals, Inc. Insider Trades
Historia transakcji

Kliknij ikonę linku, aby zobaczyć pełną historię transakcji. Transakcje zgłoszone w ramach automatycznego planu handlowego 10b5-1 będą oznaczone znakiem X w kolumnie oznaczonej 10b-5.

Plik
Data		 Data
transakcji		 Formularz Wtajemniczony Serce Nazwa papieru wartościowego Kod 10b5-1 Bezpośredni Cena
wykonania		 Cena
jednostki		 Zmieniono
jednostki		 Zmieniona
wartość (1 tys.)		 Pozostałe
opcje		 Pozostałe
akcje
2026-05-29 2026-05-27 4 Yea Christopher KALV Common Stock S - Sale D 26,7818 -33 800 -905 229 918
2026-05-29 2026-05-27 4 Yea Christopher KALV Common Stock M - Exercise D 7,0700 33 800 239 263 718
2026-05-27 2026-05-26 4 Audhya Paul K. KALV Common Stock S - Sale D 26,7778 -2 239 -60 150 260
2026-05-27 2026-05-22 4 Audhya Paul K. KALV Common Stock M - Exercise D 5 000 152 499
2026-05-27 2026-05-26 4 Sweeny Nicole KALV Common Stock S - Sale D 26,7778 -1 489 -40 59 291
2026-05-27 2026-05-22 4 Sweeny Nicole KALV Common Stock M - Exercise D 5 000 60 780
2026-05-27 2026-05-26 4 Yea Christopher KALV Common Stock S - Sale D 26,7778 -1 966 -53 229 918
2026-05-27 2026-05-22 4 Yea Christopher KALV Common Stock M - Exercise D 3 125 231 884
2026-05-26 2026-05-22 4 Piekos Brian KALV Common Stock S - Sale D 26,7844 -1 489 -40 21 661
2026-05-26 2026-05-21 4 Piekos Brian KALV Common Stock M - Exercise D 5 000 23 150
2026-05-26 2026-05-22 4 Audhya Paul K. KALV Common Stock S - Sale D 26,7844 -2 685 -72 147 499
2026-05-26 2026-05-21 4 Audhya Paul K. KALV Common Stock M - Exercise D 6 250 150 184
2026-05-26 2026-05-22 4 Yea Christopher KALV Common Stock S - Sale D 26,7844 -2 358 -63 228 759
2026-05-26 2026-05-21 4 Yea Christopher KALV Common Stock M - Exercise D 3 750 231 117
2026-05-26 2026-05-22 4 Sweeny Nicole KALV Common Stock S - Sale D 26,7844 -1 861 -50 55 780
2026-05-26 2026-05-21 4 Sweeny Nicole KALV Common Stock M - Exercise D 6 250 57 641
2026-05-26 2026-05-22 4 Palleiko Benjamin L KALV Common Stock S - Sale D 26,7844 -10 926 -293 479 989
2026-05-26 2026-05-21 4 Palleiko Benjamin L KALV Common Stock M - Exercise D 23 250 490 915
2026-05-19 2026-05-18 4 Palleiko Benjamin L KALV Common Stock S - Sale D 26,7600 -1 129 -30 467 665
2026-05-19 2026-05-17 4 Palleiko Benjamin L KALV Common Stock M - Exercise D 2 419 468 794
2026-05-19 2026-05-18 4 Audhya Paul K. KALV Common Stock S - Sale D 26,7600 -1 032 -28 143 934
2026-05-19 2026-05-17 4 Audhya Paul K. KALV Common Stock M - Exercise D 2 419 144 966
2026-05-19 2026-05-18 4 Yea Christopher KALV Common Stock S - Sale D 26,7600 -1 108 -30 227 367
2026-05-19 2026-05-17 4 Yea Christopher KALV Common Stock M - Exercise D 1 774 228 475
2026-05-13 2026-05-12 4 Palleiko Benjamin L KALV Common Stock S - Sale D 26,7100 -3 322 -89 466 375
2026-05-13 2026-05-11 4 Palleiko Benjamin L KALV Common Stock M - Exercise D 7 120 469 697
2026-04-20 2026-04-17 4 Audhya Paul K. KALV Common Stock S - Sale D 20,2163 -2 686 -54 142 547
2026-04-20 2026-04-16 4 Audhya Paul K. KALV Common Stock M - Exercise D 6 250 145 233
2026-04-20 2026-04-17 4 Sweeny Nicole KALV Common Stock S - Sale D 20,2163 -1 862 -38 51 391
2026-04-20 2026-04-16 4 Sweeny Nicole KALV Common Stock M - Exercise D 6 250 53 253
2026-04-20 2026-04-17 4 Palleiko Benjamin L KALV Common Stock S - Sale D 20,2163 -9 550 -193 462 577
2026-04-20 2026-04-16 4 Palleiko Benjamin L KALV Common Stock M - Exercise D 20 312 472 127
2026-04-20 2026-04-17 4 Piekos Brian KALV Common Stock S - Sale D 20,2163 -1 862 -38 18 150
2026-04-20 2026-04-16 4 Piekos Brian KALV Common Stock M - Exercise D 6 250 20 012
2026-03-27 2026-03-26 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock S - Sale I 19,1200 -3 183 -61 5 089 354
2026-03-27 2026-03-26 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock S - Sale I 18,8200 -15 417 -290 5 092 537
2026-03-27 2026-03-26 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock S - Sale I 17,7600 -21 386 -380 5 107 954
2026-03-27 2026-03-25 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock S - Sale I 17,5300 -160 -3 5 129 340
2026-03-27 2026-03-25 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock S - Sale I 16,9500 -174 485 -2 958 5 129 500
2026-03-10 2026-03-09 4 Palleiko Benjamin L KALV Common Stock S - Sale D 16,0814 -6 693 -108 451 815
2026-03-10 2026-03-06 4 Palleiko Benjamin L KALV Common Stock M - Exercise D 15 625 458 508
2026-02-24 2026-02-23 4 Audhya Paul K. KALV Common Stock S - Sale D 15,5668 -5 354 -83 138 983
2026-02-24 2026-02-22 4 Audhya Paul K. KALV Common Stock M - Exercise D 5 000 144 337
2026-02-24 2026-02-21 4 Audhya Paul K. KALV Common Stock M - Exercise D 6 250 139 337
2026-02-24 2026-02-23 4 Palleiko Benjamin L KALV Common Stock S - Sale D 15,5668 -10 034 -156 442 883
2026-02-24 2026-02-21 4 Palleiko Benjamin L KALV Common Stock M - Exercise D 23 250 452 917
2026-02-24 2026-02-23 4 Yea Christopher KALV Common Stock S - Sale D 15,5668 -4 347 -68 226 701
2026-02-24 2026-02-22 4 Yea Christopher KALV Common Stock M - Exercise D 3 125 231 048
2026-02-24 2026-02-21 4 Yea Christopher KALV Common Stock M - Exercise D 3 750 227 923
2026-02-24 2026-02-23 4 Sweeny Nicole KALV Common Stock S - Sale D 15,5668 -3 975 -62 47 003
2026-02-24 2026-02-22 4 Sweeny Nicole KALV Common Stock M - Exercise D 5 000 50 978
2026-02-24 2026-02-21 4 Sweeny Nicole KALV Common Stock M - Exercise D 6 250 45 978
2026-02-24 2026-02-23 4 Piekos Brian KALV Common Stock S - Sale D 15,5668 -1 767 -28 13 762
2026-02-24 2026-02-21 4 Piekos Brian KALV Common Stock M - Exercise D 5 000 15 529
2026-02-19 2026-02-18 4 Audhya Paul K. KALV Common Stock S - Sale D 15,0000 -1 163 -17 133 087
2026-02-19 2026-02-17 4 Audhya Paul K. KALV Common Stock M - Exercise D 2 419 134 250
2026-02-19 2026-02-18 4 Palleiko Benjamin L KALV Common Stock S - Sale D 15,0000 -1 038 -16 429 667
2026-02-19 2026-02-17 4 Palleiko Benjamin L KALV Common Stock M - Exercise D 2 419 430 705
2026-02-19 2026-02-18 4 Yea Christopher KALV Common Stock S - Sale D 15,0000 -1 109 -17 224 173
2026-02-19 2026-02-17 4 Yea Christopher KALV Common Stock M - Exercise D 1 774 225 282
2026-02-13 2026-02-12 4 Palleiko Benjamin L KALV Common Stock S - Sale D 15,7000 -3 354 -53 428 286
2026-02-13 2026-02-11 4 Palleiko Benjamin L KALV Common Stock M - Exercise D 7 120 431 640
2025-12-09 2025-12-08 4 Palleiko Benjamin L KALV Common Stock S - Sale D 16,5100 -7 294 -120 424 520
2025-12-09 2025-12-06 4 Palleiko Benjamin L KALV Common Stock M - Exercise D 15 625 431 814
2025-12-04 2025-11-24 4 Sweeny Nicole KALV Common Stock S - Sale D 13,4510 -3 813 -51 39 728
2025-12-04 2025-11-22 4 Sweeny Nicole KALV Common Stock M - Exercise D 5 000 43 541
2025-12-04 2025-11-21 4 Sweeny Nicole KALV Common Stock M - Exercise D 6 250 38 541
2025-11-26 2025-11-24 4 Piekos Brian KALV Common Stock S - Sale D 13,4510 -4 471 -60 10 529
2025-11-26 2025-11-21 4 Piekos Brian KALV Common Stock M - Exercise D 15 000 15 000
2025-11-26 2025-11-24 4 Yea Christopher KALV Common Stock S - Sale D 13,4510 -4 331 -58 223 508
2025-11-26 2025-11-22 4 Yea Christopher KALV Common Stock M - Exercise D 3 125 227 839
2025-11-26 2025-11-21 4 Yea Christopher KALV Common Stock M - Exercise D 3 750 224 714
2025-11-26 2025-11-24 4 Audhya Paul K. KALV Common Stock S - Sale D 13,4510 -5 296 -71 131 831
2025-11-26 2025-11-22 4 Audhya Paul K. KALV Common Stock M - Exercise D 5 000 137 127
2025-11-26 2025-11-21 4 Audhya Paul K. KALV Common Stock M - Exercise D 6 250 132 127
2025-11-26 2025-11-24 4 Palleiko Benjamin L KALV Common Stock S - Sale D 13,4510 -10 940 -147 416 189
2025-11-26 2025-11-21 4 Palleiko Benjamin L KALV Common Stock M - Exercise D 23 250 427 129
2025-11-21 2025-11-20 4 Yea Christopher KALV Common Stock M - Exercise D 0,0043 87 390 0 220 964
2025-11-19 2025-11-18 4 Palleiko Benjamin L KALV Common Stock S - Sale D 14,4794 -4 466 -65 403 879
2025-11-19 2025-11-17 4 Palleiko Benjamin L KALV Common Stock M - Exercise D 9 364 408 345
2025-11-19 2025-11-18 4 Yea Christopher KALV Common Stock S - Sale D 14,4794 -2 683 -39 133 574
2025-11-19 2025-11-17 4 Yea Christopher KALV Common Stock M - Exercise D 4 205 136 257
2025-11-19 2025-11-18 4 Audhya Paul K. KALV Common Stock S - Sale D 14,4795 -3 075 -45 125 877
2025-11-19 2025-11-17 4 Audhya Paul K. KALV Common Stock M - Exercise D 6 447 128 952
2025-11-13 2025-11-12 4 Palleiko Benjamin L KALV Common Stock S - Sale D 11,5500 -3 328 -38 398 981
2025-11-13 2025-11-11 4 Palleiko Benjamin L KALV Common Stock M - Exercise D 7 120 402 309
2025-09-09 2025-09-08 4 Palleiko Benjamin L KALV Common Stock S - Sale D 15,8400 -7 294 -116 395 189
2025-09-09 2025-09-06 4 Palleiko Benjamin L KALV Common Stock M - Exercise D 15 625 402 483
2025-08-26 2025-08-25 4 Sweeny Nicole KALV Common Stock S - Sale D 13,4200 -1 480 -20 32 291
2025-08-26 2025-08-22 4 Sweeny Nicole KALV Common Stock M - Exercise D 5 000 33 771
2025-08-26 2025-08-25 4 Yea Christopher KALV Common Stock S - Sale D 13,4200 -1 954 -26 132 052
2025-08-26 2025-08-22 4 Yea Christopher KALV Common Stock M - Exercise D 3 125 134 006
2025-08-26 2025-08-25 4 Audhya Paul K. KALV Common Stock S - Sale D 13,4200 -2 336 -31 122 505
2025-08-26 2025-08-22 4 Audhya Paul K. KALV Common Stock M - Exercise D 5 000 124 841
2025-08-25 2025-08-22 4 Sweeny Nicole KALV Common Stock S - Sale D 13,2228 -1 864 -25 28 771
2025-08-25 2025-08-21 4 Sweeny Nicole KALV Common Stock M - Exercise D 6 250 30 635
2025-08-25 2025-08-22 4 Yea Christopher KALV Common Stock S - Sale D 13,2228 -2 362 -31 130 881
2025-08-25 2025-08-21 4 Yea Christopher KALV Common Stock M - Exercise D 3 750 133 243
2025-08-25 2025-08-22 4 Audhya Paul K. KALV Common Stock S - Sale D 13,2228 -2 942 -39 119 841
2025-08-25 2025-08-21 4 Audhya Paul K. KALV Common Stock M - Exercise D 6 250 122 783
2025-08-25 2025-08-22 4 Palleiko Benjamin L KALV Common Stock S - Sale D 13,2228 -10 940 -145 386 858
2025-08-25 2025-08-21 4 Palleiko Benjamin L KALV Common Stock M - Exercise D 23 250 397 798
2025-08-19 2025-08-18 4 Yea Christopher KALV Common Stock S - Sale D 13,1870 -2 649 -35 129 493
2025-08-19 2025-08-17 4 Yea Christopher KALV Common Stock M - Exercise D 4 203 132 142
2025-08-19 2025-08-18 4 Audhya Paul K. KALV Common Stock S - Sale D 13,1870 -2 939 -39 116 533
2025-08-19 2025-08-17 4 Audhya Paul K. KALV Common Stock M - Exercise D 6 446 119 472
2025-08-19 2025-08-18 4 Palleiko Benjamin L KALV Common Stock S - Sale D 13,1870 -4 409 -58 374 548
2025-08-19 2025-08-17 4 Palleiko Benjamin L KALV Common Stock M - Exercise D 9 362 378 957
2025-07-10 2025-07-09 4 Palleiko Benjamin L KALV Common Stock S - Sale D 15,6925 -32 979 -518 369 595
2025-07-10 2025-07-08 4 Palleiko Benjamin L KALV Common Stock A - Award D 87 500 402 574
2025-07-10 2025-07-09 4 Yea Christopher KALV Common Stock S - Sale D 15,6925 -30 250 -475 127 939
2025-07-10 2025-07-08 4 Yea Christopher KALV Common Stock A - Award D 60 000 158 189
2025-06-10 2025-06-09 4 Palleiko Benjamin L KALV Common Stock S - Sale D 14,5000 -7 169 -104 315 074
2025-06-10 2025-06-06 4 Palleiko Benjamin L KALV Common Stock M - Exercise D 15 625 322 243
2025-05-27 2025-05-23 4 Audhya Paul K. KALV Common Stock S - Sale D 11,3102 -2 146 -24 113 026
2025-05-27 2025-05-22 4 Audhya Paul K. KALV Common Stock M - Exercise D 5 000 115 172
2025-05-27 2025-05-23 4 Yea Christopher KALV Common Stock S - Sale D 11,3093 -1 926 -22 98 189
2025-05-27 2025-05-22 4 Yea Christopher KALV Common Stock M - Exercise D 3 125 100 115
2025-05-23 2025-05-22 4 Audhya Paul K. KALV Common Stock S - Sale D 11,8755 -2 689 -32 110 172
2025-05-23 2025-05-21 4 Audhya Paul K. KALV Common Stock M - Exercise D 6 250 112 861
2025-05-23 2025-05-22 4 Yea Christopher KALV Common Stock S - Sale D 11,8755 -2 317 -28 96 990
2025-05-23 2025-05-21 4 Yea Christopher KALV Common Stock M - Exercise D 3 750 99 307
2025-05-23 2025-05-22 4 Palleiko Benjamin L KALV Common Stock S - Sale D 11,8755 -9 999 -119 306 618
2025-05-23 2025-05-21 4 Palleiko Benjamin L KALV Common Stock M - Exercise D 23 250 316 617
2025-05-20 2025-05-19 4 Palleiko Benjamin L KALV Common Stock S - Sale D 11,8428 -3 808 -45 293 367
2025-05-20 2025-05-17 4 Palleiko Benjamin L KALV Common Stock M - Exercise D 9 364 297 175
2025-05-20 2025-05-19 4 Yea Christopher KALV Common Stock S - Sale D 11,8428 -2 600 -31 95 557
2025-05-20 2025-05-17 4 Yea Christopher KALV Common Stock M - Exercise D 4 205 98 157
2025-05-20 2025-05-19 4 Audhya Paul K. KALV Common Stock S - Sale D 11,8428 -2 776 -33 106 611
2025-05-20 2025-05-17 4 Audhya Paul K. KALV Common Stock M - Exercise D 6 447 109 387
2025-04-11 2025-04-09 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock P - Purchase I 9,4200 25 000 236 5 303 985
2025-03-10 2025-03-07 4 Palleiko Benjamin L KALV Common Stock S - Sale D 11,9700 -6 669 -80 287 811
2025-03-10 2025-03-06 4 Palleiko Benjamin L KALV Common Stock M - Exercise D 15 625 294 480
2025-02-25 2025-02-24 4 Audhya Paul K. KALV Common Stock S - Sale D 10,0200 -2 394 -24 102 940
2025-02-25 2025-02-22 4 Audhya Paul K. KALV Common Stock M - Exercise D 5 000 105 334
2025-02-25 2025-02-24 4 Yea Christopher KALV Common Stock S - Sale D 10,0200 -1 918 -19 93 952
2025-02-25 2025-02-22 4 Yea Christopher KALV Common Stock M - Exercise D 3 125 95 870
2025-02-19 2025-02-18 4 Audhya Paul K. KALV Common Stock S - Sale D 9,8242 -3 125 -31 100 334
2025-02-19 2025-02-17 4 Audhya Paul K. KALV Common Stock M - Exercise D 6 447 103 459
2025-02-19 2025-02-18 4 Yea Christopher KALV Common Stock S - Sale D 9,8242 -2 601 -26 92 745
2025-02-19 2025-02-17 4 Yea Christopher KALV Common Stock M - Exercise D 4 204 95 346
2025-02-19 2025-02-18 4 Palleiko Benjamin L KALV Common Stock S - Sale D 9,8242 -5 104 -50 278 855
2025-02-19 2025-02-17 4 Palleiko Benjamin L KALV Common Stock M - Exercise D 9 363 283 959
2025-02-14 2025-02-13 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock P - Purchase I 9,3300 61 700 576 5 278 985
2025-02-14 2025-02-12 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock P - Purchase I 9,2300 100 000 923 5 217 285
2025-02-11 2025-02-11 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock P - Purchase I 9,1800 26 703 245 5 117 285
2025-02-11 2025-02-10 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock P - Purchase I 9,1400 4 137 38 5 090 582
2025-02-11 2025-02-07 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock P - Purchase I 9,2900 73 649 684 5 086 445
2025-02-03 2025-02-03 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock P - Purchase I 9,2200 14 562 134 5 012 796
2025-02-03 2025-01-31 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock P - Purchase I 8,8900 11 754 104 4 998 234
2025-02-03 2025-01-30 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock P - Purchase I 8,7600 43 707 383 4 986 480
2025-02-03 3 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock I 4 942 773
2024-12-09 2024-12-09 4 Palleiko Benjamin L KALV Common Stock S - Sale D 9,7500 -7 627 -74 274 596
2024-12-09 2024-12-06 4 Palleiko Benjamin L KALV Common Stock M - Exercise D 15 625 282 223
2024-11-27 2024-11-26 4 Audhya Paul K. KALV Common Stock S - Sale D 9,8702 -2 187 -22 97 012
2024-11-27 2024-11-22 4 Audhya Paul K. KALV Common Stock M - Exercise D 5 000 99 199
2024-11-27 2024-11-26 4 Yea Christopher KALV Common Stock S - Sale D 9,8718 -1 963 -19 91 142
2024-11-27 2024-11-22 4 Yea Christopher KALV Common Stock M - Exercise D 3 125 93 105
2024-11-19 2024-11-18 4 Palleiko Benjamin L KALV Common Stock S - Sale D 9,2565 -14 400 -133 266 598
2024-11-19 2024-11-17 4 Palleiko Benjamin L KALV Common Stock M - Exercise D 30 198 280 998
2024-11-19 2024-11-18 4 Yea Christopher KALV Common Stock S - Sale D 9,2565 -7 192 -67 89 980
2024-11-19 2024-11-17 4 Yea Christopher KALV Common Stock M - Exercise D 11 496 97 172
2024-11-19 2024-11-18 4 Audhya Paul K. KALV Common Stock S - Sale D 9,2566 -8 077 -75 94 199
2024-11-19 2024-11-17 4 Audhya Paul K. KALV Common Stock M - Exercise D 18 531 102 276
2024-09-10 2024-09-09 4 Palleiko Benjamin L KALV Common Stock S - Sale D 12,1901 -7 352 -90 250 800
2024-09-10 2024-09-06 4 Palleiko Benjamin L KALV Common Stock M - Exercise D 15 625 258 152
2024-08-26 2024-08-23 4 Audhya Paul K. KALV Common Stock S - Sale D 12,4000 -2 135 -26 83 745
2024-08-26 2024-08-22 4 Audhya Paul K. KALV Common Stock M - Exercise D 5 000 85 880
2024-08-26 2024-08-23 4 Yea Christopher KALV Common Stock S - Sale D 12,4000 -1 916 -24 85 676
2024-08-26 2024-08-22 4 Yea Christopher KALV Common Stock M - Exercise D 3 125 87 592
2024-08-21 2024-08-19 4 Palleiko Benjamin L KALV Common Stock S - Sale D 12,0133 -14 215 -171 242 527
2024-08-21 2024-08-17 4 Palleiko Benjamin L KALV Common Stock M - Exercise D 30 195 256 742
2024-08-21 2024-08-19 4 Audhya Paul K. KALV Common Stock S - Sale D 12,0133 -7 973 -96 80 880
2024-08-21 2024-08-17 4 Audhya Paul K. KALV Common Stock M - Exercise D 18 528 88 853
2024-08-21 2024-08-19 4 Yea Christopher KALV Common Stock S - Sale D 12,0133 -7 102 -85 84 467
2024-08-21 2024-08-17 4 Yea Christopher KALV Common Stock M - Exercise D 11 495 91 569
2024-06-10 2024-06-07 4 Palleiko Benjamin L KALV Common Stock S - Sale D 11,5296 -7 465 -86 224 547
2024-06-10 2024-06-06 4 Palleiko Benjamin L KALV Common Stock M - Exercise D 15 625 232 012
2024-05-21 2024-05-20 4 Feener Edward P. KALV Common Stock S - Sale D 11,7645 -8 088 -95 72 858
2024-05-21 2024-05-17 4 Feener Edward P. KALV Common Stock M - Exercise D 18 789 80 946
2024-05-21 2024-05-20 4 Audhya Paul K. KALV Common Stock S - Sale D 11,7645 -13 175 -155 70 325
2024-05-21 2024-05-17 4 Audhya Paul K. KALV Common Stock M - Exercise D 30 614 83 500
2024-05-21 2024-05-20 4 Palleiko Benjamin L KALV Common Stock S - Sale D 11,7645 -21 959 -258 216 387
2024-05-21 2024-05-17 4 Palleiko Benjamin L KALV Common Stock M - Exercise D 51 031 238 346
2024-05-21 2024-05-20 4 Yea Christopher KALV Common Stock S - Sale D 11,7645 -11 610 -137 80 074
2024-05-21 2024-05-17 4 Yea Christopher KALV Common Stock M - Exercise D 18 789 91 684
2024-02-21 2024-02-20 4 Feener Edward P. KALV Common Stock S - Sale D 14,7200 -300 -4 62 157
2024-02-21 2024-02-20 4 Feener Edward P. KALV Common Stock S - Sale D 14,0366 -19 591 -275 62 457
2024-02-21 2024-02-20 4 Feener Edward P. KALV Common Stock S - Sale D 14,1148 -8 397 -119 82 048
2024-02-21 2024-02-17 4 Feener Edward P. KALV Common Stock M - Exercise D 18 788 90 445
2024-02-21 2024-02-20 4 Yea Christopher KALV Common Stock S - Sale D 14,1147 -12 053 -170 72 895
2024-02-21 2024-02-17 4 Yea Christopher KALV Common Stock M - Exercise D 18 788 84 948
2024-02-21 2024-02-20 4 Palleiko Benjamin L KALV Common Stock S - Sale D 14,1148 -22 802 -322 187 315
2024-02-21 2024-02-17 4 Palleiko Benjamin L KALV Common Stock M - Exercise D 51 029 210 117
2024-02-21 2024-02-20 4 Audhya Paul K. KALV Common Stock S - Sale D 14,1150 -14 295 -202 52 886
2024-02-21 2024-02-17 4 Audhya Paul K. KALV Common Stock M - Exercise D 30 613 67 181
2024-02-21 2024-02-20 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 14,1148 -24 888 -351 211 203
2024-02-21 2024-02-17 4 Crockett Thomas Andrew KALV Common Stock M - Exercise D 54 415 236 091
2024-02-16 2024-02-14 4 Palleiko Benjamin L KALV Common Stock S - Sale D 15,0093 -40 855 -613 159 088
2024-02-16 2024-02-14 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 15,0093 -58 356 -876 181 676
2024-02-16 2024-02-14 4 Feener Edward P. KALV Common Stock S - Sale D 15,0093 -28 171 -423 71 657
2024-02-16 2024-02-14 4 Yea Christopher KALV Common Stock S - Sale D 15,0093 -39 886 -599 66 160
2024-02-13 2024-02-11 4 Palleiko Benjamin L KALV Common Stock A - Award D 87 500 199 943
2024-02-13 2024-02-11 4 Feener Edward P. KALV Common Stock A - Award D 60 000 99 828
2024-02-13 2024-02-11 4 Yea Christopher KALV Common Stock A - Award D 60 000 106 046
2024-02-13 2024-02-11 4 Crockett Thomas Andrew KALV Common Stock A - Award D 122 500 240 032
2024-02-08 2024-02-08 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock P - Purchase I 14,7000 29 747 437 4 824 731
2024-02-08 2024-02-07 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock P - Purchase I 14,5600 51 827 755 4 794 984
2024-02-08 2024-02-06 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock P - Purchase I 14,7400 4 474 66 4 743 157
2024-02-05 2024-02-01 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 16,8143 -700 -12 117 532
2024-02-05 2024-02-01 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 16,1751 -9 300 -150 118 232
2024-02-01 2024-01-30 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock P - Purchase I 14,4700 88 099 1 275 4 738 683
2024-01-29 2024-01-29 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock P - Purchase I 14,2200 80 600 1 146 4 650 584
2024-01-29 2024-01-26 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock P - Purchase I 12,9800 4 174 54 4 569 984
2024-01-29 2024-01-25 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock P - Purchase I 12,7300 7 030 89 4 565 810
2024-01-24 2024-01-24 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock P - Purchase I 12,4400 20 686 257 4 558 780
2024-01-24 2024-01-23 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock P - Purchase I 12,5400 10 897 137 4 538 094
2024-01-24 2024-01-22 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock P - Purchase I 12,5500 67 546 848 4 527 197
2024-01-19 2024-01-19 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock P - Purchase I 12,4300 25 000 311 4 459 651
2024-01-19 2024-01-18 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock P - Purchase I 12,5100 39 680 496 4 434 651
2024-01-19 2024-01-17 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock P - Purchase I 12,6000 78 925 994 4 394 971
2024-01-16 2024-01-16 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock P - Purchase I 12,7300 19 599 249 4 316 046
2024-01-16 2024-01-11 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock P - Purchase I 12,6800 6 647 84 4 296 447
2024-01-12 2024-01-11 4 Feener Edward P. KALV Common Stock S - Sale D 13,0303 -22 679 -296 39 828
2024-01-10 2024-01-10 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock P - Purchase I 12,6700 47 700 604 4 289 800
2024-01-10 2024-01-09 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock P - Purchase I 12,5600 20 816 261 4 242 100
2024-01-10 2024-01-08 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock P - Purchase I 12,4400 69 184 861 4 221 284
2024-01-10 2024-01-09 4 Feener Edward P. KALV Common Stock S - Sale D 13,0000 -100 -1 62 507
2024-01-10 2024-01-08 4 Feener Edward P. KALV Common Stock S - Sale D 13,0074 -17 221 -224 62 607
2024-01-05 2024-01-04 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock P - Purchase I 12,1100 41 764 506 4 152 100
2024-01-05 2024-01-03 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock P - Purchase I 12,2000 17 605 215 4 110 336
2023-12-29 2023-12-29 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock P - Purchase I 12,4900 6 013 75 4 092 731
2023-12-29 2023-12-28 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock P - Purchase I 12,5000 471 490 5 894 4 086 718
2023-12-29 2023-12-27 4 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock P - Purchase I 11,9700 41 514 497 3 615 228
2023-12-28 2023-12-27 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 12,0151 -30 000 -360 127 532
2023-12-28 3 Venrock Healthcare Capital Partners III, L.P. By Funds KALV Common Stock I 3 573 714
2023-11-21 2023-11-20 4 Palleiko Benjamin L KALV Common Stock S - Sale D 8,2293 -13 008 -107 112 443
2023-11-21 2023-11-17 4 Palleiko Benjamin L KALV Common Stock M - Exercise D 30 197 125 451
2023-11-21 2023-11-20 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 8,2293 -14 807 -122 157 532
2023-11-21 2023-11-17 4 Crockett Thomas Andrew KALV Common Stock M - Exercise D 33 583 172 339
2023-11-21 2023-11-20 4 Yea Christopher KALV Common Stock S - Sale D 8,2293 -7 113 -59 46 046
2023-11-21 2023-11-17 4 Yea Christopher KALV Common Stock M - Exercise D 11 497 53 159
2023-11-21 2023-11-20 4 Feener Edward P. KALV Common Stock S - Sale D 8,2293 -4 958 -41 79 828
2023-11-21 2023-11-17 4 Feener Edward P. KALV Common Stock M - Exercise D 11 497 84 786
2023-11-21 2023-11-20 4 Audhya Paul K. KALV Common Stock S - Sale D 8,2293 -7 985 -66 36 568
2023-11-21 2023-11-17 4 Audhya Paul K. KALV Common Stock M - Exercise D 18 530 44 553
2023-11-01 2023-10-30 4 Crockett Thomas Andrew KALV Common Stock G - Gift D -8 000 138 756
2023-09-13 2023-09-11 4 CHA ALBERT KALV Common Stock S - Sale D 10,5028 -18 000 -189 0
2023-09-13 2023-09-11 4 CHA ALBERT KALV Common Stock M - Exercise D 7,8800 12 000 95 18 000
2023-09-13 2023-09-11 4 CHA ALBERT KALV Common Stock M - Exercise D 6,7100 6 000 40 6 000
2023-08-21 2023-08-18 4 Audhya Paul K. KALV Common Stock S - Sale D 10,7288 -8 020 -86 26 023
2023-08-21 2023-08-17 4 Audhya Paul K. KALV Common Stock M - Exercise D 18 529 34 043
2023-08-21 2023-08-18 4 Feener Edward P. KALV Common Stock S - Sale D 10,7287 -4 976 -53 73 289
2023-08-21 2023-08-17 4 Feener Edward P. KALV Common Stock M - Exercise D 11 494 78 265
2023-08-21 2023-08-18 4 Yea Christopher KALV Common Stock S - Sale D 10,7287 -7 142 -77 41 662
2023-08-21 2023-08-17 4 Yea Christopher KALV Common Stock M - Exercise D 11 494 48 804
2023-08-21 2023-08-18 4 Palleiko Benjamin L KALV Common Stock S - Sale D 10,7287 -13 067 -140 95 254
2023-08-21 2023-08-17 4 Palleiko Benjamin L KALV Common Stock M - Exercise D 30 195 108 321
2023-08-21 2023-08-18 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 10,7288 -14 876 -160 146 756
2023-08-21 2023-08-17 4 Crockett Thomas Andrew KALV Common Stock M - Exercise D 33 582 161 632
2023-05-19 2023-05-18 4 Palleiko Benjamin L KALV Common Stock S - Sale D 10,1444 -4 037 -41 78 126
2023-05-19 2023-05-17 4 Palleiko Benjamin L KALV Common Stock M - Exercise D 9 364 82 163
2023-05-19 2023-05-18 4 Yea Christopher KALV Common Stock S - Sale D 10,1444 -2 604 -26 37 310
2023-05-19 2023-05-17 4 Yea Christopher KALV Common Stock M - Exercise D 4 205 39 914
2023-05-19 2023-05-18 4 Feener Edward P. KALV Common Stock S - Sale D 10,1444 -1 786 -18 66 771
2023-05-19 2023-05-17 4 Feener Edward P. KALV Common Stock M - Exercise D 4 205 68 557
2023-05-19 2023-05-18 4 Audhya Paul K. KALV Common Stock S - Sale D 10,1444 -2 780 -28 13 014
2023-05-19 2023-05-17 4 Audhya Paul K. KALV Common Stock M - Exercise D 6 447 15 794
2023-05-19 2023-05-18 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 10,1444 -5 627 -57 128 050
2023-05-19 2023-05-17 4 Crockett Thomas Andrew KALV Common Stock M - Exercise D 12 750 133 677
2023-02-23 2023-02-17 4 Palleiko Benjamin L KALV Common Stock S - Sale D 7,6600 -4 954 -38 72 799
2023-02-23 2023-02-17 4 Palleiko Benjamin L KALV Common Stock M - Exercise D 9 363 77 753
2023-02-23 2023-02-17 4 Yea Christopher KALV Common Stock S - Sale D 7,6600 -2 727 -21 35 709
2023-02-23 2023-02-17 4 Yea Christopher KALV Common Stock M - Exercise D 4 204 38 436
2023-02-23 2023-02-17 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 7,6600 -6 700 -51 120 927
2023-02-23 2023-02-17 4 Crockett Thomas Andrew KALV Common Stock M - Exercise D 12 749 127 627
2023-02-23 2023-02-17 4 Feener Edward P. KALV Common Stock S - Sale D 7,6600 -2 228 -17 64 352
2023-02-23 2023-02-17 4 Feener Edward P. KALV Common Stock M - Exercise D 4 204 66 580
2023-02-23 2023-02-17 4 Audhya Paul K. KALV Common Stock S - Sale D 7,6600 -3 412 -26 9 347
2023-02-23 2023-02-17 4 Audhya Paul K. KALV Common Stock M - Exercise D 6 446 6 313
2022-11-21 2022-11-18 4 Yea Christopher KALV Common Stock S - Sale D 5,4400 -1 139 -6 34 232
2022-11-21 2022-11-17 4 Yea Christopher KALV Common Stock M - Exercise D 1 774 35 371
2022-11-21 2022-11-18 4 Palleiko Benjamin L KALV Common Stock S - Sale D 5,4400 -722 -4 68 390
2022-11-21 2022-11-17 4 Palleiko Benjamin L KALV Common Stock M - Exercise D 2 419 69 112
2022-11-21 2022-11-18 4 Feener Edward P. KALV Common Stock S - Sale D 5,4400 -530 -3 62 376
2022-11-21 2022-11-17 4 Feener Edward P. KALV Common Stock M - Exercise D 1 774 62 906
2022-11-21 2022-11-18 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 5,4400 -1 785 -10 114 878
2022-11-21 2022-11-17 4 Crockett Thomas Andrew KALV Common Stock M - Exercise D 5 805 116 663
2022-11-21 2022-11-18 4 Audhya Paul K. KALV Common Stock S - Sale D 5,4400 -722 -4 5 946
2022-11-21 2022-11-17 4 Audhya Paul K. KALV Common Stock M - Exercise D 2 419 6 668
2022-09-07 2022-09-02 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 17,0134 -1 320 -22 110 858
2022-09-07 2022-07-02 4 Crockett Thomas Andrew KALV Common Stock G - Gift D -6 500 112 178
2022-08-19 2022-08-17 4 Audhya Paul K. KALV Common Stock S - Sale D 14,9615 -725 -11 1 693
2022-08-19 2022-08-17 4 Audhya Paul K. KALV Common Stock M - Exercise D 2 418 2 418
2022-08-19 2022-08-17 4 Yea Christopher KALV Common Stock S - Sale D 14,9607 -1 145 -17 33 597
2022-08-19 2022-08-17 4 Yea Christopher KALV Common Stock M - Exercise D 1 773 34 742
2022-08-19 2022-08-17 4 Feener Edward P. KALV Common Stock S - Sale D 14,9619 -532 -8 61 132
2022-08-19 2022-08-17 4 Feener Edward P. KALV Common Stock M - Exercise D 1 773 61 664
2022-08-19 2022-08-17 4 Palleiko Benjamin L KALV Common Stock S - Sale D 14,9608 -725 -11 66 693
2022-08-19 2022-08-17 4 Palleiko Benjamin L KALV Common Stock M - Exercise D 2 418 67 418
2022-08-19 2022-08-17 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 14,9641 -1 797 -27 112 178
2022-08-19 2022-08-17 4 Crockett Thomas Andrew KALV Common Stock M - Exercise D 5 805 113 975
2022-05-27 2022-05-26 4 Treanor Patrick KALV Stock Option (right to buy) A - Award D 8,60 17 000 17 000
2022-05-19 2022-05-17 4 Audhya Paul K. KALV Restricted Stock Units A - Award D 38 700 38 700
2022-05-19 2022-05-17 4 Audhya Paul K. KALV Employee Stock Option (Right to Buy) A - Award D 9,28 25 800 25 800
2022-05-19 2022-05-17 4 Feener Edward P. KALV Restricted Stock Units A - Award D 28 380 28 380
2022-05-19 2022-05-17 4 Feener Edward P. KALV Employee Stock Option (Right to Buy) A - Award D 9,28 18 920 18 920
2022-05-19 2022-05-17 4 Yea Christopher KALV Restricted Stock Units A - Award D 28 380 28 380
2022-05-19 2022-05-17 4 Yea Christopher KALV Employee Stock Option (Right to Buy) A - Award D 9,28 18 920 18 920
2022-05-19 2022-05-17 4 Smith Michael David KALV Restricted Stock Units A - Award D 15 480 15 480
2022-05-19 2022-05-17 4 Smith Michael David KALV Employee Stock Option (Right to Buy) A - Award D 9,28 10 320 10 320
2022-05-19 2022-05-17 4 Crockett Thomas Andrew KALV Restricted Stock Units A - Award D 92 880 92 880
2022-05-19 2022-05-17 4 Crockett Thomas Andrew KALV Employee Stock Option (Right to Buy) A - Award D 9,28 61 920 61 920
2022-05-19 2022-05-17 4 Palleiko Benjamin L KALV Restricted Stock Units A - Award D 38 700 38 700
2022-05-19 2022-05-17 4 Palleiko Benjamin L KALV Employee Stock Option (Right to Buy) A - Award D 9,28 25 800 25 800
2022-03-11 2022-03-09 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 17,0693 -10 000 -171 114 670
2022-01-11 2022-01-07 4 Feener Edward P. KALV Employee Stock Option (right to buy) M - Exercise D 8,21 -23 857 27 943
2022-01-11 2022-01-07 4 Feener Edward P. KALV Employee Stock Option (right to buy) M - Exercise D 7,07 -33 800 0
2022-01-11 2022-01-07 4 Feener Edward P. KALV Common Stock M - Exercise D 8,2100 23 857 196 59 891
2022-01-11 2022-01-07 4 Feener Edward P. KALV Common Stock M - Exercise D 7,0700 33 800 239 36 034
2021-11-03 2021-11-01 4 Feener Edward P. KALV Common Stock S - Sale D 18,0706 -6 000 -108 2 234
2021-11-03 2021-11-01 4 Yea Christopher KALV Common Stock S - Sale D 18,0656 -5 000 -90 32 969
2021-10-04 2021-10-01 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 17,1841 -10 000 -172 124 670
2021-10-04 2021-09-30 4 Edwards Martin KALV Director Stock Option (Right to Buy) A - Award D 17,45 10 000 10 000
2021-10-01 2021-09-30 4 Unkart Edward W KALV Director Stock Option (Right to Buy) A - Award D 17,45 10 000 10 000
2021-10-01 2021-09-30 4 SOLAND DANIEL B KALV Director Stock Option (Right to Buy) A - Award D 17,45 10 000 10 000
2021-10-01 2021-09-30 4 Pereira Brian JG KALV Director Stock Option (Right to Buy) A - Award D 17,45 10 000 10 000
2021-10-01 2021-09-30 4 CHA ALBERT KALV Director Stock Option (Right to Buy) A - Award D 17,45 10 000 10 000
2021-08-04 2021-08-02 4 Yea Christopher KALV Common Stock S - Sale D 20,5157 -5 000 -103 37 969
2021-08-04 2021-08-02 4 Feener Edward P. KALV Common Stock S - Sale D 20,5223 -6 000 -123 8 234
2021-07-02 2021-07-01 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 24,3548 -5 650 -138 134 670
2021-07-02 2021-07-01 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 23,8787 -4 350 -104 140 320
2021-06-22 2021-06-17 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 30,0380 -1 067 -32 144 670
2021-06-11 2021-06-09 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 30,0549 -8 933 -268 145 737
2021-06-03 2021-06-01 4 Smith Michael David KALV Stock Option (right to buy) M - Exercise D 8,39 -7 500 22 596
2021-06-03 2021-06-01 4 Smith Michael David KALV Common Stock S - Sale D 26,8295 -7 500 -201 0
2021-06-03 2021-06-01 4 Smith Michael David KALV Common Stock M - Exercise D 8,3900 7 500 63 7 500
2021-06-03 2021-06-02 4 Feener Edward P. KALV Common Stock S - Sale D 27,0461 -1 062 -29 14 234
2021-06-03 2021-06-02 4 Feener Edward P. KALV Common Stock S - Sale D 26,3341 -7 138 -188 15 296
2021-06-03 2021-06-01 4 Feener Edward P. KALV Common Stock S - Sale D 27,2111 -14 -0 22 434
2021-06-03 2021-06-01 4 Feener Edward P. KALV Common Stock S - Sale D 26,8085 -25 786 -691 22 448
2021-05-28 2021-05-26 4 Smith Michael David KALV Employee Stock Option (Right to Buy) A - Award D 25,95 35 000 35 000
2021-05-28 2021-05-26 4 Feener Edward P. KALV Employee Stock Option (Right to Buy) A - Award D 25,95 60 000 60 000
2021-05-28 2021-05-26 4 Yea Christopher KALV Employee Stock Option (Right to Buy) A - Award D 25,95 60 000 60 000
2021-05-28 2021-05-26 4 Palleiko Benjamin L KALV Employee Stock Option (Right to Buy) A - Award D 25,95 75 000 75 000
2021-05-28 2021-05-26 4 Crockett Thomas Andrew KALV Employee Stock Option (Right to Buy) A - Award D 25,95 200 000 200 000
2021-05-28 2021-04-29 4 Crockett Thomas Andrew KALV Common Stock G - Gift D -4 750 154 670
2021-05-28 2021-05-26 4 Maetzel Andreas KALV Employee Stock Option (Right to Buy) A - Award D 25,95 25 000 25 000
2021-05-07 2021-05-03 4/A Feener Edward P. KALV Common Stock S - Sale D 24,8418 -6 000 -149 48 234
2021-05-06 2021-05-03 4 Yea Christopher KALV Common Stock S - Sale D 24,8393 -5 000 -124 42 969
2021-05-06 2021-05-03 4 Feener Edward P. KALV Employee Stock Option (right to buy) M - Exercise D 10,21 -6 000 20 255
2021-05-06 2021-05-03 4 Feener Edward P. KALV Common Stock S - Sale D 24,8418 -6 000 -149 54 234
2021-05-06 2021-05-03 4 Feener Edward P. KALV Common Stock M - Exercise D 10,2100 6 000 61 60 234
2021-05-04 2021-05-01 4 Audhya Paul K. KALV Employee Stock Option (right to buy) A - Award D 24,97 100 000 100 000
2021-04-30 2021-04-28 4 Smith Michael David KALV Stock Option (right to buy) M - Exercise D 8,39 -10 014 30 096
2021-04-30 2021-04-28 4 Smith Michael David KALV Common Stock S - Sale D 25,7622 -10 014 -258 0
2021-04-30 2021-04-28 4 Smith Michael David KALV Common Stock M - Exercise D 8,3900 10 014 84 10 014
2021-04-29 2021-04-29 4 Maetzel Andreas KALV Employee Stock Option (right to buy) M - Exercise D 16,08 -13 368 7 332
2021-04-29 2021-04-29 4 Maetzel Andreas KALV Employee Stock Option (right to buy) M - Exercise D 8,21 -14 662 6 038
2021-04-29 2021-04-29 4 Maetzel Andreas KALV Employee Stock Option (right to buy) M - Exercise D 7,91 -12 856 0
2021-04-29 2021-04-29 4 Maetzel Andreas KALV Common Stock S - Sale D 25,0352 -40 886 -1 024 0
2021-04-29 2021-04-29 4 Maetzel Andreas KALV Common Stock M - Exercise D 16,0800 13 368 215 40 886
2021-04-29 2021-04-29 4 Maetzel Andreas KALV Common Stock M - Exercise D 8,2100 14 662 120 27 518
2021-04-29 2021-04-29 4 Maetzel Andreas KALV Common Stock M - Exercise D 7,9100 12 856 102 12 856
2021-04-29 2021-04-28 4 Maetzel Andreas KALV Employee Stock Option (right to buy) M - Exercise D 7,91 -36 127 12 856
2021-04-29 2021-04-28 4 Maetzel Andreas KALV Common Stock S - Sale D 25,6500 -507 -13 0
2021-04-29 2021-04-28 4 Maetzel Andreas KALV Common Stock S - Sale D 25,5387 -10 000 -255 507
2021-04-29 2021-04-28 4 Maetzel Andreas KALV Common Stock S - Sale D 25,2522 -15 000 -379 10 507
2021-04-29 2021-04-28 4 Maetzel Andreas KALV Common Stock S - Sale D 25,5000 -10 620 -271 25 507
2021-04-29 2021-04-28 4 Maetzel Andreas KALV Common Stock M - Exercise D 7,9100 36 127 286 36 127
2021-04-29 2021-04-27 4 Maetzel Andreas KALV Employee Stock Option (right to buy) M - Exercise D 7,91 -11 017 48 983
2021-04-29 2021-04-27 4 Maetzel Andreas KALV Common Stock S - Sale D 25,7931 -11 017 -284 0
2021-04-29 2021-04-27 4 Maetzel Andreas KALV Common Stock M - Exercise D 7,9100 11 017 87 11 017
2021-04-05 2021-04-01 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 28,1125 -800 -22 159 420
2021-04-05 2021-04-01 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 27,4812 -8 500 -234 160 220
2021-04-05 2021-04-01 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 26,2229 -700 -18 168 720
2021-03-19 2021-03-18 4 Stuart Nancy KALV Employee Stock Option (Right to Buy) A - Award D 34,27 14 000 14 000
2021-02-25 2021-02-23 4 Yea Christopher KALV Common Stock S - Sale D 31,8660 -500 -16 47 969
2021-02-25 2021-02-23 4 Yea Christopher KALV Common Stock S - Sale D 32,9383 -3 311 -109 48 469
2021-02-25 2021-02-23 4 Yea Christopher KALV Common Stock S - Sale D 33,7445 -10 389 -351 51 780
2021-02-25 2021-02-23 4 Yea Christopher KALV Common Stock S - Sale D 35,3925 -800 -28 62 169
2021-02-25 2021-02-23 4 Palleiko Benjamin L KALV Employee Stock Option (right to buy) M - Exercise D 6,74 -29 642 29 611
2021-02-25 2021-02-23 4 Palleiko Benjamin L KALV Common Stock S - Sale D 31,7741 -1 256 -40 65 000
2021-02-25 2021-02-23 4 Palleiko Benjamin L KALV Common Stock S - Sale D 33,0578 -5 293 -175 66 256
2021-02-25 2021-02-23 4 Palleiko Benjamin L KALV Common Stock S - Sale D 33,7335 -22 093 -745 71 549
2021-02-25 2021-02-23 4 Palleiko Benjamin L KALV Common Stock S - Sale D 35,4044 -1 000 -35 93 642
2021-02-25 2021-02-23 4 Palleiko Benjamin L KALV Common Stock M - Exercise D 6,7400 29 642 200 94 642
2021-02-25 2021-02-23 4 Feener Edward P. KALV Common Stock S - Sale D 31,7303 -800 -25 54 234
2021-02-25 2021-02-23 4 Feener Edward P. KALV Common Stock S - Sale D 32,9738 -5 471 -180 55 034
2021-02-25 2021-02-23 4 Feener Edward P. KALV Common Stock S - Sale D 33,7244 -23 441 -791 60 505
2021-02-25 2021-02-23 4 Feener Edward P. KALV Common Stock S - Sale D 35,1901 -1 288 -45 83 946
2021-02-25 2021-02-23 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 31,8685 -707 -23 169 420
2021-02-25 2021-02-23 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 32,9380 -1 575 -52 170 127
2021-02-25 2021-02-23 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 33,7254 -7 218 -243 171 702
2021-02-25 2021-02-23 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 35,4000 -500 -18 178 920
2021-02-08 2021-02-07 4 Smith Michael David KALV Stock Option (right to buy) A - Award D 10,20 16 500 16 500
2021-02-08 2021-02-07 4 Yea Christopher KALV Stock Option (right to buy) A - Award D 10,20 20 000 20 000
2021-02-08 2021-02-07 4 Yea Christopher KALV Stock Option (right to buy) A - Award D 24,23 31 000 31 000
2021-02-08 2021-02-07 4 Maetzel Andreas KALV Stock Option (right to buy) A - Award D 24,23 10 000 10 000
2021-02-08 2021-02-07 4 Maetzel Andreas KALV Stock Option (right to buy) A - Award D 10,20 10 000 10 000
2021-02-08 2021-02-07 4 Palleiko Benjamin L KALV Stock Option (right to buy) A - Award D 10,20 20 000 20 000
2021-02-08 2021-02-07 4 Palleiko Benjamin L KALV Stock Option (right to buy) A - Award D 24,23 37 500 37 500
2021-02-08 2021-02-07 4 Palleiko Benjamin L KALV Common Stock A - Award D 32 500 65 000
2021-02-08 2021-02-07 4 Feener Edward P. KALV Stock Option (right to buy) A - Award D 10,20 20 000 20 000
2021-02-08 2021-02-07 4 Feener Edward P. KALV Stock Option (right to buy) A - Award D 24,23 22 500 22 500
2021-02-08 2021-02-07 4 Feener Edward P. KALV Common Stock A - Award D 12 500 85 234
2021-02-08 2021-02-07 4 Crockett Thomas Andrew KALV Stock Option (right to buy) A - Award D 10,20 40 000 40 000
2021-02-08 2021-02-07 4 Crockett Thomas Andrew KALV Stock Option (right to buy) A - Award D 24,23 75 000 75 000
2021-01-06 2021-01-04 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 18,8530 -814 -15 185 420
2021-01-06 2021-01-04 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 18,1317 -9 186 -167 186 234
2021-01-06 2020-10-29 4 Crockett Thomas Andrew KALV Common Stock G - Gift D -6 000 179 420
2021-01-04 2020-12-30 4 Palleiko Benjamin L KALV Employee Stock Option (right to buy) M - Exercise D 6,74 -358 59 253
2021-01-04 2020-12-30 4 Palleiko Benjamin L KALV Common Stock S - Sale D 20,0413 -358 -7 32 500
2021-01-04 2020-12-30 4 Palleiko Benjamin L KALV Common Stock M - Exercise D 6,7400 358 2 32 858
2020-12-18 2020-12-16 4 Yea Christopher KALV Stock Option (right to buy) A - Award D 10,20 80 000 80 000
2020-12-18 2020-12-16 4 Smith Michael David KALV Stock Option (right to buy) A - Award D 10,20 25 000 25 000
2020-12-18 2020-12-16 4 Palleiko Benjamin L KALV Stock Option (right to buy) A - Award D 10,20 85 000 85 000
2020-12-18 2020-12-16 4 Maetzel Andreas KALV Stock Option (right to buy) A - Award D 10,20 20 000 20 000
2020-12-18 2020-12-16 4 Feener Edward P. KALV Stock Option (right to buy) A - Award D 10,20 65 000 65 000
2020-12-18 2020-12-16 4 Crockett Thomas Andrew KALV Stock Option (right to buy) A - Award D 10,20 140 000 140 000
2020-11-04 2020-11-02 4 Feener Edward P. KALV Common Stock S - Sale D 17,1353 -6 000 -103 72 734
2020-11-03 2020-10-30 4 CHA ALBERT By Vivo Opportunity Fund, L.P. KALV Common Stock P - Purchase I 17,3359 47 431 822 1 138 179
2020-11-03 2020-10-30 4 CHA ALBERT By Vivo Opportunity Fund, L.P. KALV Common Stock P - Purchase I 17,1681 68 255 1 172 1 090 748
2020-11-02 2020-10-29 4 Yea Christopher KALV Common Stock S - Sale D 17,4788 -5 000 -87 62 969
2020-10-22 2020-10-21 4 Yea Christopher KALV Common Stock S - Sale D 19,0207 -2 544 -48 67 969
2020-10-22 2020-10-21 4 Yea Christopher KALV Common Stock S - Sale D 17,6837 -3 500 -62 70 513
2020-10-22 2020-10-20 4 Yea Christopher KALV Common Stock S - Sale D 18,0133 -2 302 -41 74 013
2020-10-22 2020-10-20 4 Yea Christopher KALV Common Stock S - Sale D 17,2729 -5 640 -97 76 315
2020-10-22 2020-10-21 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 19,0072 -3 693 -70 195 420
2020-10-22 2020-10-21 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 18,5137 -13 052 -242 199 113
2020-10-22 2020-10-21 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 17,4849 -5 800 -101 212 165
2020-10-22 2020-10-20 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 18,0050 -4 776 -86 217 965
2020-10-22 2020-10-20 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 17,2746 -11 218 -194 222 741
2020-10-22 2020-10-21 4 Feener Edward P. KALV Common Stock S - Sale D 18,7487 -5 407 -101 78 734
2020-10-22 2020-10-21 4 Feener Edward P. KALV Common Stock S - Sale D 17,6539 -3 600 -64 84 141
2020-10-22 2020-10-20 4 Feener Edward P. KALV Common Stock S - Sale D 18,0030 -2 300 -41 87 741
2020-10-22 2020-10-20 4 Feener Edward P. KALV Common Stock S - Sale D 17,2649 -5 600 -97 90 041
2020-10-20 2020-10-16 4 Yea Christopher KALV Common Stock S - Sale D 17,0014 -914 -16 81 955
2020-10-20 2020-10-16 4 Feener Edward P. KALV Common Stock S - Sale D 17,0000 -993 -17 95 641
2020-10-20 2020-10-16 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 17,0056 -1 261 -21 236 959
2020-10-20 2020-04-29 4 Crockett Thomas Andrew KALV Common Stock G - Gift D -3 000 233 959
2020-10-02 2020-10-01 4 SOLAND DANIEL B KALV Director Stock Option (right to buy) A - Award D 12,88 7 000 7 000
2020-10-02 2020-10-01 4 SOLAND DANIEL B KALV Director Stock Option (right to buy) A - Award D 12,88 7 000 7 000
2020-10-02 2020-10-01 4 Unkart Edward W KALV Director Stock Option (right to buy) A - Award D 12,88 7 000 7 000
2020-10-02 2020-10-01 4 Edwards Martin KALV Director Stock Option (right to buy) A - Award D 12,88 7 000 7 000
2020-10-02 2020-10-01 4 CHA ALBERT KALV Director Stock Option (right to buy) A - Award D 12,88 7 000 7 000
2020-10-02 2020-10-01 4 ORONSKY ARNOLD L KALV Director Stock Option (right to buy) A - Award D 12,88 7 000 7 000
2020-10-02 2020-10-01 4 Pereira Brian JG KALV Director Stock Option (right to buy) A - Award D 12,88 7 000 7 000
2020-02-07 2020-02-05 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 17,0500 -200 -3 238 220
2020-02-07 2020-02-05 4 Feener Edward P. KALV Common Stock S - Sale D 17,1100 -100 -2 96 634
2020-02-07 2020-02-05 4 Yea Christopher KALV Common Stock S - Sale D 17,1000 -100 -2 82 869
2019-12-26 2019-12-20 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 17,0219 -2 300 -39 238 420
2019-12-26 2019-12-20 4 Yea Christopher KALV Employee Stock Option (Right to Buy) M - Exercise D 0,00 -2 646 87 390
2019-12-26 2019-12-20 4 Yea Christopher KALV Common Stock S - Sale D 17,0163 -2 646 -45 82 969
2019-12-26 2019-12-20 4 Yea Christopher KALV Common Stock M - Exercise D 0,0043 2 646 0 85 615
2019-12-16 2019-12-16 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 17,0585 -5 400 -92 240 720
2019-12-16 2019-12-13 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 17,0620 -2 200 -38 246 120
2019-12-16 2019-12-12 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 17,0000 -100 -2 248 320
2019-12-16 2019-12-16 4 Yea Christopher KALV Employee Stock Option (Right to Buy) M - Exercise D 0,00 -3 010 90 036
2019-12-16 2019-12-16 4 Yea Christopher KALV Common Stock S - Sale D 17,0493 -3 010 -51 82 969
2019-12-16 2019-12-16 4 Yea Christopher KALV Common Stock M - Exercise D 0,0043 3 010 0 85 979
2019-12-16 2019-12-13 4 Yea Christopher KALV Employee Stock Option (Right to Buy) M - Exercise D 0,00 -1 500 93 046
2019-12-16 2019-12-13 4 Yea Christopher KALV Common Stock S - Sale D 17,0453 -1 500 -26 82 969
2019-12-16 2019-12-13 4 Yea Christopher KALV Common Stock M - Exercise D 0,0043 1 500 0 84 469
2019-12-16 2019-12-12 4 Yea Christopher KALV Employee Stock Option (Right to Buy) M - Exercise D 0,00 -199 94 546
2019-12-16 2019-12-12 4 Yea Christopher KALV Common Stock S - Sale D 17,0000 -199 -3 82 969
2019-12-16 2019-12-12 4 Yea Christopher KALV Common Stock M - Exercise D 0,0043 199 0 83 168
2019-10-03 2019-10-02 4 Unkart Edward W KALV Director Stock Option (Right to Buy) A - Award D 11,21 11,2100 7 000 78 7 000
2019-10-03 2019-10-02 4 ORONSKY ARNOLD L KALV Director Stock Option (Right to Buy) A - Award D 11,21 7 000 7 000
2019-10-03 2019-10-02 4 CHA ALBERT KALV Director Stock Option (Right to Buy) A - Award D 11,21 7 000 7 000
2019-09-30 2019-09-27 4 SOLAND DANIEL B KALV Common Stock P - Purchase D 11,8686 7 962 94 10 000
2019-09-30 2019-09-26 4 SOLAND DANIEL B KALV Common Stock P - Purchase D 11,9000 2 038 24 2 038
2019-07-30 2019-07-29 4 CHA ALBERT By Vivo Capital Fund IX, L.P. KALV Common Stock P - Purchase I 17,1327 5 137 88 124 566
2019-07-30 2019-07-29 4 CHA ALBERT By Vivo Opportunity Fund, L.P. KALV Common Stock P - Purchase I 17,1327 24 730 424 1 022 493
2019-07-30 2019-07-26 4 CHA ALBERT By Vivo Opportunity Fund, L.P. KALV Common Stock P - Purchase I 16,8315 21 942 369 997 763
2019-07-30 2019-07-26 4 CHA ALBERT By Vivo Capital Fund IX, L.P. KALV Common Stock P - Purchase I 16,8315 4 558 77 119 429
2019-07-24 2019-07-23 4 Feener Edward P. KALV Common Stock S - Sale D 18,6521 -1 900 -35 96 734
2019-07-24 2019-07-22 4 Feener Edward P. KALV Common Stock S - Sale D 18,5743 -1 400 -26 98 634
2019-07-24 2019-07-22 4 Yea Christopher KALV Employee Stock Option (Right to Buy) M - Exercise D 0,00 -7 355 94 745
2019-07-24 2019-07-22 4 Yea Christopher KALV Common Stock S - Sale D 18,3453 -7 355 -135 82 969
2019-07-24 2019-07-22 4 Yea Christopher KALV Common Stock M - Exercise D 0,0043 7 355 0 90 324
2019-07-19 2019-07-19 4 CHA ALBERT By Vivo Opportunity Fund, L.P. KALV Common Stock P - Purchase I 17,8367 49 680 886 975 821
2019-07-19 2019-07-19 4 CHA ALBERT By Vivo Capital Fund IX, L.P. KALV Common Stock P - Purchase I 17,6796 10 320 182 114 871
2019-07-19 2019-07-17 4 CHA ALBERT By Vivo Capital Fund IX, L.P. KALV Common Stock P - Purchase I 16,9273 220 4 104 551
2019-07-19 2019-07-17 4 CHA ALBERT By Vivo Opportunity Fund, L.P. KALV Common Stock P - Purchase I 16,9726 1 060 18 926 141
2019-07-17 2019-07-15 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 17,0407 -10 000 -170 248 510
2019-06-28 3 Edwards Martin KALV No Securities are beneficially owned D 0
2019-06-28 2019-06-26 4 Edwards Martin KALV Employee Stock Option (Right to Buy) A - Award D 20,62 14 000 14 000
2019-05-17 2019-05-15 4 Palleiko Benjamin L KALV Employee Stock Option (Right to Buy) A - Award D 24,23 33 750 33 750
2019-05-17 2019-05-15 4 Feener Edward P. KALV Employee Stock Option (Right to Buy) A - Award D 24,23 20 250 20 250
2019-05-17 2019-05-15 4 Maetzel Andreas KALV Employee Stock Option (Right to Buy) A - Award D 24,23 9 000 9 000
2019-05-17 2019-05-15 4 Yea Christopher KALV Employee Stock Option (Right to Buy) A - Award D 24,23 27 900 27 900
2019-05-17 2019-05-15 4 Crockett Thomas Andrew KALV Employee Stock Option (Right to Buy) A - Award D 24,23 67 500 67 500
2019-04-23 3 SOLAND DANIEL B KALV No Securities are beneficially owned D 0
2019-04-23 2019-04-22 4 SOLAND DANIEL B KALV Director Stock Option (Right to Buy) A - Award D 26,40 14 000 14 000
2019-04-23 2019-04-15 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 25,9233 -300 -8 258 510
2019-04-23 2019-04-15 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 24,7609 -9 700 -240 258 810
2019-04-23 2019-04-22 4 Yea Christopher KALV Employee Stock Option (Right to Buy) M - Exercise D 0,00 -7 355 102 100
2019-04-23 2019-04-22 4 Yea Christopher KALV Common Stock S - Sale D 26,7860 -1 000 -27 82 969
2019-04-23 2019-04-22 4 Yea Christopher KALV Common Stock S - Sale D 25,9235 -6 355 -165 83 969
2019-04-23 2019-04-22 4 Yea Christopher KALV Common Stock M - Exercise D 0,0043 7 355 0 90 324
2019-04-22 2019-04-22 4 Palleiko Benjamin L KALV Employee Stock Option (Right to Buy) M - Exercise D 8,39 -2 000 47 354
2019-04-22 2019-04-22 4 Palleiko Benjamin L KALV Common Stock S - Sale D 25,8015 -2 000 -52 32 500
2019-04-22 2019-04-22 4 Palleiko Benjamin L KALV Common Stock M - Exercise D 8,3900 2 000 17 34 500
2019-04-22 2019-04-18 4 Palleiko Benjamin L KALV Employee Stock Option (Right to Buy) M - Exercise D 6,74 -1 073 59 611
2019-04-22 2019-04-18 4 Palleiko Benjamin L KALV Common Stock S - Sale D 25,5111 -1 073 -27 32 500
2019-04-22 2019-04-18 4 Palleiko Benjamin L KALV Common Stock M - Exercise D 6,7400 1 073 7 33 573
2019-04-18 2019-04-17 4 Feener Edward P. KALV Common Stock S - Sale D 25,3932 -916 -23 100 034
2019-04-18 2019-04-17 4 Feener Edward P. KALV Common Stock S - Sale D 24,7750 -3 084 -76 100 950
2019-04-10 2019-04-10 4 SVLSF IV, LLC KALV Common Stock S - Sale D 29,3952 -374 -11 47 471
2019-04-10 2019-04-10 4 SVLSF IV, LLC KALV Common Stock S - Sale D 29,3952 -13 157 -387 1 672 105
2019-04-10 2019-04-09 4 SVLSF IV, LLC KALV Common Stock S - Sale D 28,5305 -377 -11 47 845
2019-04-10 2019-04-09 4 SVLSF IV, LLC KALV Common Stock S - Sale D 28,5305 -13 292 -379 1 685 262
2019-04-10 2019-04-08 4 SVLSF IV, LLC KALV Common Stock S - Sale D 29,4919 -629 -19 48 222
2019-04-10 2019-04-08 4 SVLSF IV, LLC KALV Common Stock S - Sale D 29,4919 -22 171 -654 1 698 554
2019-04-09 2019-04-05 4 Maetzel Andreas KALV Employee Stock Option (Right to Buy) M - Exercise D 7,91 -5 000 60 000
2019-04-09 2019-04-05 4 Maetzel Andreas KALV Common Stock S - Sale D 30,0022 -5 000 -150 0
2019-04-09 2019-04-05 4 Maetzel Andreas KALV Common Stock M - Exercise D 7,9100 5 000 40 5 000
2019-04-02 2019-04-02 4 SVLSF IV, LLC KALV Common Stock S - Sale D 28,7638 -253 -7 48 851
2019-04-02 2019-04-02 4 SVLSF IV, LLC KALV Common Stock S - Sale D 28,7638 -8 888 -256 1 720 725
2019-04-02 2019-04-01 4 SVLSF IV, LLC KALV Common Stock S - Sale D 27,6582 -1 458 -40 49 104
2019-04-02 2019-04-01 4 SVLSF IV, LLC KALV Common Stock S - Sale D 27,6582 -51 373 -1 421 1 729 613
2019-04-02 2019-03-29 4 SVLSF IV, LLC KALV Common Stock S - Sale D 28,3960 -969 -28 50 562
2019-04-02 2019-03-29 4 SVLSF IV, LLC KALV Common Stock S - Sale D 28,3960 -34 133 -969 1 780 986
2019-03-28 2019-03-28 4 SVLSF IV, LLC KALV Common Stock S - Sale D 27,8010 -1 012 -28 51 531
2019-03-28 2019-03-28 4 SVLSF IV, LLC KALV Common Stock S - Sale D 27,8010 -35 653 -991 1 815 119
2019-03-28 2019-03-27 4 SVLSF IV, LLC KALV Common Stock S - Sale D 29,0592 -1 599 -46 52 543
2019-03-28 2019-03-27 4 SVLSF IV, LLC KALV Common Stock S - Sale D 29,0592 -56 318 -1 637 1 850 772
2019-03-28 2019-03-26 4 SVLSF IV, LLC KALV Common Stock S - Sale D 29,6975 -831 -25 54 142
2019-03-28 2019-03-26 4 SVLSF IV, LLC KALV Common Stock S - Sale D 29,6975 -29 262 -869 1 907 090
2019-03-20 2019-03-18 4 Venrock Healthcare Capital Partners II, L.P. By Funds KALV Common Stock S - Sale I 28,7500 -500 000 -14 375 1 544 112
2019-03-20 2019-03-18 4 SVLSF IV, LLC KALV Common Stock S - Sale D 26,7000 -7 246 -193 54 973
2019-03-20 2019-03-18 4 SVLSF IV, LLC KALV Common Stock S - Sale D 26,7000 -255 224 -6 814 1 936 352
2019-03-15 2019-03-14 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 30,1613 -3 000 -90 268 510
2019-03-06 2019-03-05 4 SVLSF IV, LLC KALV Common Stock S - Sale D 23,0365 -893 -21 62 219
2019-03-06 2019-03-05 4 SVLSF IV, LLC KALV Common Stock S - Sale D 23,0365 -31 439 -724 2 191 576
2019-03-06 2019-03-04 4 SVLSF IV, LLC KALV Common Stock S - Sale D 22,9070 -1 197 -27 63 112
2019-03-06 2019-03-04 4 SVLSF IV, LLC KALV Common Stock S - Sale D 22,9070 -42 181 -966 2 223 015
2019-02-21 2019-02-21 4 SVLSF IV, LLC KALV Common Stock S - Sale D 20,6000 -4 764 -98 64 309
2019-02-21 2019-02-21 4 SVLSF IV, LLC KALV Common Stock S - Sale D 20,6000 -167 779 -3 456 2 265 196
2019-02-21 2019-02-20 4 SVLSF IV, LLC KALV Common Stock S - Sale D 20,0159 -641 -13 69 073
2019-02-21 2019-02-20 4 SVLSF IV, LLC KALV Common Stock S - Sale D 20,0159 -22 594 -452 2 432 975
2019-02-21 2019-02-19 4 SVLSF IV, LLC KALV Common Stock S - Sale D 20,7328 -508 -11 69 714
2019-02-21 2019-02-19 4 SVLSF IV, LLC KALV Common Stock S - Sale D 20,7328 -17 912 -371 2 455 569
2019-02-05 3 Pereira Brian JG KALV No Securities are beneficially owned D 0
2019-02-05 2019-02-01 4 Pereira Brian JG KALV Director Stock Option (Right to Buy) A - Award D 17,95 14 000 14 000
2019-01-29 2019-01-25 4 Yea Christopher KALV Employee Stock Option (Right to Buy) M - Exercise D 0,00 -5 453 109 455
2019-01-29 2019-01-25 4 Yea Christopher KALV Common Stock S - Sale D 17,0576 -5 453 -93 82 969
2019-01-29 2019-01-25 4 Yea Christopher KALV Common Stock M - Exercise D 0,0043 5 453 0 88 422
2019-01-24 2016-11-21 4/A Yea Christopher KALV Employee Stock Option (Right to Buy) A - Award D 0,00 116 810 116 810
2019-01-24 2019-01-23 4 Yea Christopher KALV Employee Stock Option (Right to Buy) M - Exercise D 0,00 -600 114 908
2019-01-24 2019-01-23 4 Yea Christopher KALV Common Stock S - Sale D 17,0083 -600 -10 82 969
2019-01-24 2019-01-23 4 Yea Christopher KALV Common Stock M - Exercise D 0,0043 600 0 83 569
2019-01-24 2019-01-22 4 Yea Christopher KALV Employee Stock Option (Right to Buy) M - Exercise D 0,00 -1 302 115 508
2019-01-24 2019-01-22 4 Yea Christopher KALV Common Stock S - Sale D 17,0038 -1 302 -22 82 969
2019-01-24 2019-01-22 4 Yea Christopher KALV Common Stock M - Exercise D 0,0043 1 302 0 84 271
2019-01-18 2019-01-16 4 Feener Edward P. KALV Common Stock S - Sale D 19,8141 -2 300 -46 104 034
2019-01-18 2019-01-16 4 Feener Edward P. KALV Common Stock S - Sale D 19,1985 -1 700 -33 106 334
2019-01-16 2019-01-14 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 19,8623 -901 -18 271 510
2019-01-16 2019-01-14 4 Crockett Thomas Andrew KALV Common Stock S - Sale D 19,2804 -9 099 -175 272 411
2019-01-07 2019-01-07 4 SVLSF IV, LLC KALV Common Stock S - Sale D 20,4120 -72 -1 70 222
2019-01-07 2019-01-07 4 SVLSF IV, LLC KALV Common Stock S - Sale D 20,4120 -2 527 -52 2 473 481
2019-01-07 2019-01-03 4 SVLSF IV, LLC KALV Common Stock S - Sale D 20,0130 -47 -1 70 294
2019-01-07 2019-01-03 4 SVLSF IV, LLC KALV Common Stock S - Sale D 20,0130 -1 653 -33 2 476 008
2019-01-02 2019-01-02 4 SVLSF IV, LLC KALV Common Stock S - Sale D 20,0000 -6 -0 70 341
2019-01-02 2019-01-02 4 SVLSF IV, LLC KALV Common Stock S - Sale D 20,0000 -194 -4 2 477 661
2019-01-02 2018-12-31 4 SVLSF IV, LLC KALV Common Stock S - Sale D 20,0040 -702 -14 70 347
2019-01-02 2018-12-31 4 SVLSF IV, LLC KALV Common Stock S - Sale D 20,0040 -24 716 -494 2 477 855
2019-01-02 2018-12-28 4 SVLSF IV, LLC KALV Common Stock S - Sale D 20,0270 -103 -2 71 049
2019-01-02 2018-12-28 4 SVLSF IV, LLC KALV Common Stock S - Sale D 20,0270 -3 631 -73 2 502 571
2018-12-21 2018-12-19 4 SVLSF IV, LLC KALV Common Stock S - Sale D 20,0180 -59 -1 71 152
2018-12-21 2018-12-19 4 SVLSF IV, LLC KALV Common Stock S - Sale D 20,0180 -2 077 -42 2 506 202
2018-10-05 2018-10-03 4 ALDRICH RICHARD KALV Director Stock Option (Right to Buy) A - Award D 22,65 7 000 7 000
2018-10-05 2018-10-03 4 CHA ALBERT KALV Director Stock Option (Right to Buy) A - Award D 22,65 7 000 7 000
2018-10-05 2018-10-03 4 ORONSKY ARNOLD L KALV Director Stock Option (Right to Buy) A - Award D 22,65 7 000 7 000
2018-10-05 2018-10-03 4 Unkart Edward W KALV Director Stock Option (Right to Buy) A - Award D 22,65 7 000 7 000
2018-09-20 2018-09-18 4 Maetzel Andreas KALV Employee Stock Option (Right to Buy) A - Award D 16,08 20 700 20 700
2018-09-20 2018-09-18 4 Crockett Thomas Andrew KALV Employee Stock Option (Right to Buy) A - Award D 16,08 150 000 150 000
2018-09-20 2018-09-18 4 Palleiko Benjamin L KALV Employee Stock Option (Right to Buy) A - Award D 16,08 52 600 52 600
2018-09-20 2018-09-18 4 Palleiko Benjamin L KALV Common Stock A - Award D 32 500 32 500
2018-09-20 2018-09-18 4 Yea Christopher KALV Employee Stock Option (Right to Buy) A - Award D 16,08 52 600 52 600
2018-09-20 2018-09-18 4 Feener Edward P. KALV Employee Stock Option (Right to Buy) A - Award D 16,08 52 600 52 600
2018-09-20 2018-09-18 4 Feener Edward P. KALV Common Stock F - Taxes D 17,0500 -2 500 -43 108 034
2018-09-20 2018-09-18 4 Feener Edward P. KALV Common Stock A - Award D 12 500 110 534
2018-09-12 2018-09-10 4 ORONSKY ARNOLD L InterWest Partners IX, L.P. KALV Common Stock P - Purchase I 17,0000 58 824 1 000 388 766
2018-09-12 2018-09-10 4 CHA ALBERT See Footnotes KALV Common Stock P - Purchase I 17,0000 1 058 824 18 000 1 359 149
2018-09-10 3 Shah Nimish P By funds KALV Common Stock I 4 088 224
2018-09-10 3 Shah Nimish P By funds KALV Common Stock I 4 088 224
2018-09-10 3 Shah Nimish P By funds KALV Common Stock I 4 088 224
2018-09-10 3 Shah Nimish P By funds KALV Common Stock I 4 088 224
2018-09-10 3 Shah Nimish P By funds KALV Common Stock I 4 088 224
2018-09-10 3 Shah Nimish P By funds KALV Common Stock I 4 088 224
2018-09-10 3 Shah Nimish P By funds KALV Common Stock I 4 088 224
2018-09-10 3 Shah Nimish P By funds KALV Common Stock I 4 088 224
2018-09-10 3 Shah Nimish P By funds KALV Common Stock I 4 088 224
2018-09-10 3 Shah Nimish P By funds KALV Common Stock I 4 088 224
2018-06-06 2018-06-04 4 Yea Christopher KALV Employee Stock Option (Right to Buy) A - Award D 8,21 53 500 53 500
2018-06-06 2018-06-04 4 Palleiko Benjamin L KALV Employee Stock Option (Right to Buy) A - Award D 8,21 71 700 71 700
2018-06-06 2018-06-04 4 Feener Edward P. KALV Employee Stock Option (Right to Buy) A - Award D 8,21 51 800 51 800
2018-06-06 2018-06-04 4 Maetzel Andreas KALV Employee Stock Option (Right to Buy) A - Award D 8,21 20 700 20 700
2018-06-06 2018-06-04 4 Crockett Thomas Andrew KALV Employee Stock Option (Right to Buy) A - Award D 8,21 130 800 130 800
2017-10-19 2017-10-12 4 ALDRICH RICHARD KALV Common Stock P - Purchase I 8,6131 565 065 4 867 934 484
2017-10-16 2017-10-12 4 Shah Rajeev M. KALV Common Stock P - Purchase I 8,5000 850 000 7 225 1 441 070
2017-10-16 2017-10-12 4 RA CAPITAL MANAGEMENT, LLC KALV Common Stock P - Purchase I 8,5000 850 000 7 225 1 441 070
2017-10-12 2017-10-12 4 Novo A/S KALV Common Stock S - Sale D 8,5000 -1 726 000 -14 671 0
2017-10-12 2017-10-12 4 Novo A/S KALV Common Stock S - Sale D 10,0200 -481 -5 1 726 000
2017-10-12 2017-10-11 4 Novo A/S KALV Common Stock S - Sale D 10,2132 -35 519 -363 1 726 481
2017-10-12 2017-10-10 4 Novo A/S KALV Common Stock S - Sale D 15,3600 -75 123 -1 154 1 762 000
2017-10-12 2017-10-10 4 Novo A/S KALV Common Stock S - Sale D 14,0667 -57 580 -810 1 837 123
2017-10-12 2017-10-10 4 Novo A/S KALV Common Stock S - Sale D 13,3892 -61 044 -817 1 894 703
2017-10-12 2017-10-10 4 Novo A/S KALV Common Stock S - Sale D 12,3246 -165 199 -2 036 1 955 747
2017-10-12 2017-10-10 4 Novo A/S KALV Common Stock S - Sale D 11,1760 -190 981 -2 134 2 120 946
2017-10-12 2017-10-10 4 Novo A/S KALV Common Stock S - Sale D 10,3567 -413 356 -4 281 2 311 927
2017-09-29 2017-09-27 4 RA CAPITAL MANAGEMENT, LLC KALV Director Stock Option (right to buy) A - Award I 6,71 6 000 6 000
2017-09-29 2017-09-27 4 ALDRICH RICHARD KALV Director Stock Option (Right to Buy) A - Award D 6,71 6 000 6 000
2017-09-29 2017-09-27 4 CHA ALBERT KALV Director Stock Option (Right to Buy) A - Award D 6,71 6 000 6 000
2017-09-29 2017-09-27 4 ORONSKY ARNOLD L KALV Director Stock Option (Right to Buy) A - Award D 6,71 6 000 6 000
2017-09-29 2017-09-27 4 Shah Rajeev M. KALV Director Stock Option (Right to Buy) A - Award D 6,71 6 000 6 000
2017-09-29 2017-09-27 4 Unkart Edward W KALV Director Stock Option (Right to Buy) A - Award D 6,71 6 000 6 000
2017-09-29 2017-09-27 4 Resnick Joshua KALV Director Stock Option (Right to Buy) A - Award D 6,71 6 000 6 000
2017-09-18 2017-09-15 4/A Novo A/S KALV Common Stock S - Sale D 7,0045 -140 744 -986 2 725 283
2017-09-18 2017-09-14 4/A Novo A/S KALV Common Stock S - Sale D 8,0500 -10 000 -80 2 866 027
2017-09-18 2017-09-13 4/A Novo A/S KALV Common Stock S - Sale D 8,0160 -25 900 -208 2 876 027
2017-09-15 2017-09-15 4 Novo A/S KALV Common Stock S - Sale D 8,0000 -3 -0 2 725 280
2017-09-15 2017-09-15 4 Novo A/S KALV Common Stock S - Sale D 7,0045 -140 744 -986 2 725 283
2017-09-15 2017-09-14 4 Novo A/S KALV Common Stock S - Sale D 8,0500 -10 000 -80 2 866 027
2017-09-15 2017-09-13 4 Novo A/S KALV Common Stock S - Sale D 8,0160 -25 900 -208 2 876 027
2017-05-26 2017-05-25 4 Yea Christopher KALV Employee Stock Option (Right to Buy) A - Award D 7,07 33 800 33 800
2017-05-26 2017-05-25 4 Palleiko Benjamin L KALV Employee Stock Option (Right to Buy) A - Award D 7,07 33 800 33 800
2017-05-26 2017-05-25 4 Crockett Thomas Andrew KALV Employee Stock Option (Right to Buy) A - Award D 7,07 187 000 187 000
2017-05-26 2017-05-25 4 Feener Edward P. KALV Employee Stock Option (Right to Buy) A - Award D 7,07 33 800 33 800
2017-03-27 2017-03-23 4 ORONSKY ARNOLD L KALV Director Stock Option (Right to Buy) A - Award D 7,88 12 000 12 000
2017-03-27 2017-03-23 4 Resnick Joshua KALV Director Stock Option (Right to Buy) A - Award D 7,88 12 000 12 000
2017-03-27 2017-03-23 4 Shah Rajeev M. KALV Director Stock Option (Right to Buy) A - Award D 7,88 12 000 12 000
2017-03-27 2017-03-23 4 Unkart Edward W KALV Director Stock Option (Right to Buy) A - Award D 7,88 12 000 12 000
2017-03-27 2017-03-23 4 ALDRICH RICHARD KALV Director Stock Option (Right to Buy) A - Award D 7,88 12 000 12 000
2017-03-27 2017-03-23 4 CHA ALBERT KALV Director Stock Option (Right to Buy) A - Award D 7,88 12 000 12 000
2017-03-27 2017-03-23 4 RA CAPITAL MANAGEMENT, LLC KALV Director Stock Option (right to buy) A - Award I 7,88 12 000 12 000
2017-03-09 2017-03-08 4 Maetzel Andreas KALV Employee Stock Option (Right to Buy) A - Award D 7,91 65 000 65 000
2016-12-30 2016-12-29 4 Palleiko Benjamin L KALV Employee Stock Option (Right to Buy) A - Award D 6,74 60 684 60 684
2016-11-30 3 Novo A/S KALV Common Stock D 5 803 854
2016-11-30 3 Novo A/S KALV Common Stock D 5 803 854
2016-11-30 3 Feener Edward P. KALV Common Stock D 196 068
2016-11-30 3 Feener Edward P. KALV Common Stock D 196 068
2016-11-30 2016-11-28 4 Feener Edward P. KALV Employee Stock Option (Right to Buy) A - Award D 10,21 20 055 20 055
2016-11-29 2016-11-21 4 ALDRICH RICHARD By Longwood Fund II LP KALV Common Stock A - Award I 369 419 369 419
2016-11-29 2016-11-21 4 Resnick Joshua By SV Life Sciences Fund IV Strategic Partners, L.P. KALV Common Stock A - Award I 71 211 71 211
2016-11-29 2016-11-21 4 Resnick Joshua By SV Life Sciences Fund IV, L.P. KALV Common Stock A - Award I 2 508 279 2 508 279
2016-11-29 2016-11-21 4 Yea Christopher KALV Employee Stock Option (Right to Buy) A - Award D 0,01 116 810 116 810
2016-11-29 2016-11-21 4 Yea Christopher KALV Common Stock A - Award D 82 969 82 969
2016-11-28 3 ORONSKY ARNOLD L By InterWest Partners IX, LP KALV Common Stock I 659 884
2016-11-28 3 ORONSKY ARNOLD L By InterWest Partners IX, LP KALV Common Stock I 659 884
2016-11-28 2016-11-22 4 Palleiko Benjamin L KALV Employee Stock Option (Right to Buy) A - Award D 8,39 49 354 49 354
2016-11-28 2016-11-21 4 Crockett Thomas Andrew KALV Common Stock A - Award D 281 420 281 420
2016-11-25 2016-11-21 4 SVLSF IV, LLC KALV Common Stock A - Award D 71 211 71 211
2016-11-25 2016-11-21 4 SVLSF IV, LLC KALV Common Stock A - Award D 2 508 279 2 508 279
2016-11-23 2016-11-21 4 RA CAPITAL MANAGEMENT, LLC KALV Common Stock A - Award I 591 070 591 070
2016-11-23 2016-11-21 4 Shah Rajeev M. See Footnote (3) KALV Common Stock A - Award I 591 070 591 070
2016-11-23 2016-11-21 4 Renzi David CBYL Stock Option (Right to Buy) M - Exercise D 7,84 -36 640 0
2016-11-23 2016-11-21 4 Renzi David CBYL Common Stock U - Other D 8,5932 -3 186 -27 0
2016-11-23 2016-11-21 4 Renzi David CBYL Common Stock F - Taxes D 8,5932 -33 454 -287 3 186
2016-11-23 2016-11-21 4 Renzi David CBYL Common Stock M - Exercise D 7,8400 36 640 287 36 640
2016-11-22 2016-11-21 4 Basta Steven L CBYL Stock Option (Right to Buy) M - Exercise D 7,84 1 125 0
2016-11-22 2016-11-21 4 Basta Steven L CBYL Common Stock U - Other D 8,5932 -99 -1 0
2016-11-22 2016-11-21 4 Basta Steven L CBYL Common Stock F - Taxes D 8,5932 -1 026 -9 99
2016-11-22 2016-11-21 4 Basta Steven L CBYL Common Stock M - Exercise D 7,8400 1 125 9 1 125
2016-11-22 2016-11-21 4 Maroney Marcee CBYL Stock Option (Right to Buy) M - Exercise D 7,84 -732 0
2016-11-22 2016-11-21 4 Maroney Marcee CBYL Stock Option (Right to Buy) M - Exercise D 7,84 -1 339 0
2016-11-22 2016-11-21 4 Maroney Marcee CBYL Stock Option (Right to Buy) M - Exercise D 7,84 -2 592 0
2016-11-22 2016-11-21 4 Maroney Marcee CBYL Common Stock U - Other D 8,5932 -409 -4 0
2016-11-22 2016-11-21 4 Maroney Marcee CBYL Common Stock F - Taxes D 8,5932 -4 255 -37 409
2016-11-22 2016-11-21 4 Maroney Marcee CBYL Common Stock M - Exercise D 7,8400 4 664 37 4 664
2016-02-02 2016-02-01 4 Saul David Joseph CBYL Stock Option (Right to Buy) A - Award D 2,47 56 000 56 000
2016-01-05 2016-01-04 4 Gravett David M. CBYL Stock Option (Right to Buy) A - Award D 3,33 100 000 100 000
2016-01-05 2016-01-04 4 Renzi David CBYL Stock Option (Right to Buy) A - Award D 3,33 283 000 283 000
2016-01-05 2016-01-04 4 McKune John CBYL Stock Option (Right to buy) A - Award D 3,33 10 000 10 000
2016-01-05 2016-01-04 4 Ramiya Premchandran CBYL Stock Option (Right to Buy) A - Award D 3,33 60 586 60 586
2016-01-05 2016-01-04 4 Maroney Marcee CBYL Stock Option (Right to Buy) A - Award D 3,33 100 000 100 000
2015-12-31 2015-12-30 4 Renzi David CBYL Stock Option (Right to Buy) M - Exercise D 0,56 -10 000 515 825
2015-12-31 2015-12-30 4 Renzi David CBYL Common Stock S - Sale D 3,7000 -10 000 -37 0
2015-12-31 2015-12-30 4 Renzi David CBYL Common Stock M - Exercise D 0,5600 10 000 6 10 000
2015-11-04 2015-11-02 4 McKune John CBYL Stock Option (Right to Buy) A - Award D 4,01 50 000 50 000
2015-08-05 2015-08-03 4 Gravett David M. CBYL Stock Option (Right to Buy) A - Award D 6,91 47 006 47 006
2015-08-05 2015-08-03 4 Maroney Marcee CBYL Stock Option (Right to Buy) A - Award D 6,91 60 831 60 831
2015-08-05 2015-08-03 4 Basta Steven L CBYL Stock Option (Right to Buy) A - Award D 6,91 15 750 15 750
2015-08-05 2015-08-03 4 Renzi David CBYL Stock Option (Right to Buy) A - Award D 6,91 276 506 276 506
2015-08-05 2015-08-03 4 Ramiya Premchandran CBYL Stock Option (Right to Buy) A - Award D 6,91 165 903 165 903
2015-08-05 2015-08-03 4 Lewis Hayley CBYL Stock Option (Right to Buy) A - Award D 6,91 33 181 33 181
2015-08-05 2015-08-03 4 Zadno Reza CBYL Stock Option (Right to Buy) A - Award D 6,91 15 750 15 750
2015-08-05 2015-08-03 4 Clapper David M CBYL Stock Option (Right to Buy) A - Award D 6,91 29 000 29 000
2015-08-05 2015-08-03 4 Unkart Edward W CBYL Stock Option (Right to Buy) A - Award D 6,91 29 000 29 000
2015-08-05 2015-08-03 4 Katkin Keith CBYL Stock Option (Right to Buy) A - Award D 6,91 29 000 29 000
2015-04-27 2015-04-14 4/A CHA ALBERT CBYL Convertible Promissory Note C - Conversion I -2 230 0
2015-04-27 2015-04-14 4/A CHA ALBERT CBYL Convertible Promissory Note C - Conversion I -304 438 0
2015-04-27 2015-04-14 4/A CHA ALBERT CBYL Convertible Promissory Note C - Conversion I -2 842 0
2015-04-27 2015-04-14 4/A CHA ALBERT CBYL Convertible Promissory Note C - Conversion I -387 960 0
2015-04-27 2015-04-14 4/A CHA ALBERT CBYL Series B Convertible Preferred Stock C - Conversion I -18 140 0
2015-04-27 2015-04-14 4/A CHA ALBERT CBYL Series B Convertible Preferred Stock C - Conversion I -2 476 452 0
2015-04-27 2015-04-14 4/A CHA ALBERT See Footnotes CBYL Common Stock P - Purchase I 5,0000 7 364 37 4 204 562
2015-04-27 2015-04-14 4/A CHA ALBERT See Footnotes CBYL Common Stock P - Purchase I 5,0000 1 005 136 5 026 4 197 198
2015-04-27 2015-04-14 4/A CHA ALBERT See Footnotes CBYL Common Stock C - Conversion I 2 230 3 192 062
2015-04-27 2015-04-14 4/A CHA ALBERT See Footnotes CBYL Common Stock C - Conversion I 304 438 3 189 832
2015-04-27 2015-04-14 4/A CHA ALBERT See Footnotes CBYL Common Stock C - Conversion I 2 842 2 885 394
2015-04-27 2015-04-14 4/A CHA ALBERT See Footnotes CBYL Common Stock C - Conversion I 387 960 2 882 552
2015-04-27 2015-04-14 4/A CHA ALBERT See Footnotes CBYL Common Stock C - Conversion I 18 140 2 494 592
2015-04-27 2015-04-14 4/A CHA ALBERT See Footnotes CBYL Common Stock C - Conversion I 2 476 452 2 476 452
2015-04-27 2015-04-24 4 Zadno Reza CBYL Stock Option (Right to Buy) A - Award D 7,45 6 250 6 250
2015-04-24 2015-04-14 4/A Vivo Ventures VI, LLC CBYL Convertible Promissory Note C - Conversion I -2 230 0
2015-04-24 2015-04-14 4/A Vivo Ventures VI, LLC CBYL Convertible Promissory Note C - Conversion I -304 438 0
2015-04-24 2015-04-14 4/A Vivo Ventures VI, LLC CBYL Convertible Promissory Note C - Conversion I -2 842 0
2015-04-24 2015-04-14 4/A Vivo Ventures VI, LLC CBYL Convertible Promissory Note C - Conversion I -387 960 0
2015-04-24 2015-04-14 4/A Vivo Ventures VI, LLC CBYL Series B Convertible Preferred Stock C - Conversion I -18 140 0
2015-04-24 2015-04-14 4/A Vivo Ventures VI, LLC CBYL Series B Convertible Preferred Stock C - Conversion I -2 476 452 0
2015-04-24 2015-04-14 4/A Vivo Ventures VI, LLC See Footnotes CBYL Common Stock P - Purchase I 5,0000 7 364 37 4 204 562
2015-04-24 2015-04-14 4/A Vivo Ventures VI, LLC See Footnotes CBYL Common Stock P - Purchase I 5,0000 1 005 136 5 026 4 197 198
2015-04-24 2015-04-14 4/A Vivo Ventures VI, LLC See Footnotes CBYL Common Stock C - Conversion I 2 230 3 192 062
2015-04-24 2015-04-14 4/A Vivo Ventures VI, LLC See Footnotes CBYL Common Stock C - Conversion I 304 438 3 189 832
2015-04-24 2015-04-14 4/A Vivo Ventures VI, LLC See Footnotes CBYL Common Stock C - Conversion I 2 842 2 885 394
2015-04-24 2015-04-14 4/A Vivo Ventures VI, LLC See Footnotes CBYL Common Stock C - Conversion I 387 960 2 882 552
2015-04-24 2015-04-14 4/A Vivo Ventures VI, LLC See Footnotes CBYL Common Stock C - Conversion I 18 140 2 494 592
2015-04-24 2015-04-14 4/A Vivo Ventures VI, LLC See Footnotes CBYL Common Stock C - Conversion I 2 476 452 2 476 452
2015-04-14 2015-04-14 4 NOHRA GUY P CBYL Convertible Promissory Note C - Conversion I -332 990 0
2015-04-14 2015-04-14 4 NOHRA GUY P CBYL Convertible Promissory Note C - Conversion I -424 346 0
2015-04-14 2015-04-14 4 NOHRA GUY P CBYL Series B Convertible Preferred Stock C - Conversion I -1 981 124 0
2015-04-14 2015-04-14 4 NOHRA GUY P CBYL Series A Convertible Preferred Stock C - Conversion I -727 590 0
2015-04-14 2015-04-14 4 NOHRA GUY P CBYL Common Stock P - Purchase I 5,0000 877 500 4 388 4 343 550
2015-04-14 2015-04-14 4 NOHRA GUY P CBYL Common Stock C - Conversion I 332 990 3 466 050
2015-04-14 2015-04-14 4 NOHRA GUY P CBYL Common Stock C - Conversion I 424 346 3 133 060
2015-04-14 2015-04-14 4 NOHRA GUY P CBYL Common Stock C - Conversion I 1 981 124 2 708 714
2015-04-14 2015-04-14 4 NOHRA GUY P CBYL Common Stock C - Conversion I 727 590 727 590
2015-04-14 2015-04-14 4 ACMP IV LLC CBYL Convertible Promissory Note C - Conversion I -332 990 0
2015-04-14 2015-04-14 4 ACMP IV LLC CBYL Convertible Promissory Note C - Conversion I -424 346 0
2015-04-14 2015-04-14 4 ACMP IV LLC CBYL Series B Convertible Preferred Stock C - Conversion I -1 981 124 0
2015-04-14 2015-04-14 4 ACMP IV LLC CBYL Series A Convertible Preferred Stock C - Conversion I -727 590 0
2015-04-14 2015-04-14 4 ACMP IV LLC CBYL Common Stock P - Purchase I 5,0000 877 500 4 388 4 343 550
2015-04-14 2015-04-14 4 ACMP IV LLC CBYL Common Stock C - Conversion I 332 990 3 466 050
2015-04-14 2015-04-14 4 ACMP IV LLC CBYL Common Stock C - Conversion I 424 346 3 133 060
2015-04-14 2015-04-14 4 ACMP IV LLC CBYL Common Stock C - Conversion I 1 981 124 2 708 714
2015-04-14 2015-04-14 4 ACMP IV LLC CBYL Common Stock C - Conversion I 727 590 727 590
2015-04-14 2015-04-14 4 CHA ALBERT CBYL Convertible Promissory Note C - Conversion I -2 230 0
2015-04-14 2015-04-14 4 CHA ALBERT CBYL Convertible Promissory Note C - Conversion I -304 438 0
2015-04-14 2015-04-14 4 CHA ALBERT CBYL Convertible Promissory Note C - Conversion I -2 842 0
2015-04-14 2015-04-14 4 CHA ALBERT CBYL Convertible Promissory Note C - Conversion I -387 960 0
2015-04-14 2015-04-14 4 CHA ALBERT CBYL Series B Convertible Preferred Stock C - Conversion I -18 142 0
2015-04-14 2015-04-14 4 CHA ALBERT CBYL Series B Convertible Preferred Stock C - Conversion I -2 476 452 0
2015-04-14 2015-04-14 4 CHA ALBERT CBYL Common Stock P - Purchase I 5,0000 7 364 37 4 204 564
2015-04-14 2015-04-14 4 CHA ALBERT CBYL Common Stock P - Purchase I 5,0000 1 005 136 5 026 4 197 200
2015-04-14 2015-04-14 4 CHA ALBERT CBYL Common Stock C - Conversion I 2 230 3 192 064
2015-04-14 2015-04-14 4 CHA ALBERT CBYL Common Stock C - Conversion I 304 438 3 189 834
2015-04-14 2015-04-14 4 CHA ALBERT CBYL Common Stock C - Conversion I 2 842 2 885 396
2015-04-14 2015-04-14 4 CHA ALBERT CBYL Common Stock C - Conversion I 387 960 2 882 554
2015-04-14 2015-04-14 4 CHA ALBERT CBYL Common Stock C - Conversion I 18 142 2 494 594
2015-04-14 2015-04-14 4 CHA ALBERT CBYL Common Stock C - Conversion I 2 476 452 2 476 452
2015-04-14 2015-04-14 4 InterWest Management Partners IX, LLC CBYL Convertible Promissory Note C - Conversion I -365 957 0
2015-04-14 2015-04-14 4 InterWest Management Partners IX, LLC CBYL Convertible Promissory Note C - Conversion I -466 357 0
2015-04-14 2015-04-14 4 InterWest Management Partners IX, LLC CBYL Series B Convertible Preferred Stock C - Conversion I -2 145 351 0
2015-04-14 2015-04-14 4 InterWest Management Partners IX, LLC CBYL Series A Convertible Preferred Stock C - Conversion I -831 531 0
2015-04-14 2015-04-14 4 InterWest Management Partners IX, LLC CBYL Common Stock P - Purchase I 5,0000 810 000 4 050 4 619 196
2015-04-14 2015-04-14 4 InterWest Management Partners IX, LLC CBYL Common Stock C - Conversion I 365 957 3 809 196
2015-04-14 2015-04-14 4 InterWest Management Partners IX, LLC CBYL Common Stock C - Conversion I 466 357 3 443 239
2015-04-14 2015-04-14 4 InterWest Management Partners IX, LLC CBYL Common Stock C - Conversion I 2 145 351 2 976 882
2015-04-14 2015-04-14 4 InterWest Management Partners IX, LLC CBYL Common Stock C - Conversion I 831 531 831 531
2015-04-14 2015-04-14 4 Vivo Ventures VI, LLC CBYL Convertible Promissory Note C - Conversion I -2 230 0
2015-04-14 2015-04-14 4 Vivo Ventures VI, LLC CBYL Convertible Promissory Note C - Conversion I -304 438 0
2015-04-14 2015-04-14 4 Vivo Ventures VI, LLC CBYL Convertible Promissory Note C - Conversion I -2 842 0
2015-04-14 2015-04-14 4 Vivo Ventures VI, LLC CBYL Convertible Promissory Note C - Conversion I -387 960 0
2015-04-14 2015-04-14 4 Vivo Ventures VI, LLC CBYL Series B Convertible Preferred Stock C - Conversion I -18 142 0
2015-04-14 2015-04-14 4 Vivo Ventures VI, LLC CBYL Series B Convertible Preferred Stock C - Conversion I -2 476 452 0
2015-04-14 2015-04-14 4 Vivo Ventures VI, LLC CBYL Common Stock P - Purchase I 5,0000 7 364 37 4 204 564
2015-04-14 2015-04-14 4 Vivo Ventures VI, LLC CBYL Common Stock P - Purchase I 5,0000 1 005 136 5 026 4 197 200
2015-04-14 2015-04-14 4 Vivo Ventures VI, LLC CBYL Common Stock C - Conversion I 2 230 3 192 064
2015-04-14 2015-04-14 4 Vivo Ventures VI, LLC CBYL Common Stock C - Conversion I 304 438 3 189 834
2015-04-14 2015-04-14 4 Vivo Ventures VI, LLC CBYL Common Stock C - Conversion I 2 842 2 885 396
2015-04-14 2015-04-14 4 Vivo Ventures VI, LLC CBYL Common Stock C - Conversion I 387 960 2 882 554
2015-04-14 2015-04-14 4 Vivo Ventures VI, LLC CBYL Common Stock C - Conversion I 18 142 2 494 594
2015-04-14 2015-04-14 4 Vivo Ventures VI, LLC CBYL Common Stock C - Conversion I 2 476 452 2 476 452
P
Otwarty rynek lub prywatny zakup niepochodnych lub pochodnych papierów wartościowych
S
Otwarty rynek lub prywatna sprzedaż niepochodnych lub pochodnych papierów wartościowych
A
Grant, nagroda lub inne nabycie papierów wartościowych od spółki (np. opcja)
C
Konwersja instrumentu pochodnego
D
Sprzedaż lub przeniesienie papierów wartościowych z powrotem do spółki
F
Zapłata ceny wykonania lub zobowiązania podatkowego z wykorzystaniem części papierów wartościowych otrzymanych od spółki
G
Darowizna papierów wartościowych przez lub na rzecz insidera
K
Swapy kapitałowe i podobne transakcje zabezpieczające
M
Wykonanie lub konwersja pochodnego papieru wartościowego otrzymanego od spółki (takiego jak opcja)
V
Transakcja dobrowolnie zgłoszona na Formularzu 4
J
Inne (wraz z przypisem opisującym transakcję)
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
DE:4XC1 23,01 €
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista

© 2015-2026 Fintel Ventures LLC. All rights reserved. Fintel® is a registered trademark.

This website is provided “as is” without any representations or warranties, express or implied. Fintel makes no representations or warranties in relation to this website or the information and materials provided on this website. Nothing on this website constitutes, or is meant to constitute, advice of any kind. If you require advice in relation to any financial matter you should consult an appropriate professional.

About Fintel
Features
Explore
Help Center